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ABSTRACT 
HDAC3 IS A CRITICAL REGULATOR OF NEURAL CREST 
PROGENITOR CELL BIOLOGY 
Nikhil Singh 
Jonathan A. Epstein 
 
Vertebrate embryogenesis relies on the coordinated development of 
multiple progenitor cell pools. Specific transcriptional programs regulate the 
specification, expansion, migration and eventual differentiation of these 
progenitor cell populations, and tight control of these programs is essential for 
normal development to occur. Class I histone deacetylases (Hdacs), including 
Hdac3, play critical roles in regulating gene transcription, through both epigenetic 
and non-epigenetic means. In this dissertation, I use mouse genetics to explore 
the previously undescribed role of Hdac3 in regulating neural crest progenitor cell 
behavior. By genetically deleting Hdac3 in premigratory neural crest cells, I use in 
vivo and ex vivo techniques to show that Hdac3 plays crucial roles in multiple 
facets of neural crest development, and that transcriptional programs involved in 
progenitor cell survival and differentiation are all under the control of this 
important enzyme. 
 
iv	  
Table of Contents 
 
Acknowledgements…………………...…………………………………………………ii 
Abstract…………………………………………………………………………………..iii 
Table of Contents………………………………………………………………….……iv 
List of Tables…………………………………………………………………………….vi 
List of Figures…………………………………..………………………………………vii 
 
Chapter 1. Introduction………………………………………………………………….1 
Summary ….………………………………………………………….…………1 
Extrinsic and intrinsic regulation of progenitor cell behavior…..…………..2 
Histone deacetylases and epigenetic regulation of gene expression…….4 
Class I Hdacs in development………………………………………………...7 
Hdac3 as a unique class I Hdac………………………………………………8 
Hdac3 in cardiac development and homeostasis…………………………10 
Neural crest development……….………….……………………………….14 
Epigenetic regulation of neural crest development……….………………16 
Conclusions……………….……….………………………………………….18 
 
 Chapter 2. Hdac3-mediated repression of Bmp4 in neural crest cells regulates 
murine craniofacial development….…..………………………………………….…24 
Summary ….…….…….…..……………………………………….…………24 
Introduction…….………………………………………………...…..……….25 
Results…..………..……………………………………………...…..……….28 
Discussion..……………….………………………………………………….40 
Materials and methods……………………..……………………………….43 
 
 Chapter 3. Hdac3 regulates smooth muscle differentiation in neural crest cells  
and development of the cardiac outflow tract.……..…………………………….…69 
v	  
Summary.….……….….…..……………………………………….…………69 
Introduction…….………………………………………………...…..……….70 
Results…..………..……………………………………………...…..……….75 
Discussion..……………….………………………………………………….84 
Materials and methods……………………..……………………………….87 
 
  Chapter 4. Conclusions and future directions……………………………..…….117 
Summary ….….……….…..……………………………………….………..117 
Discussion and future directions…….…………………………………….119 
Concluding remarks…..……………………..……………..……………….129 
 
  Appendix. Diet-induced lethality due to deletion of the Hdac3 gene in heart           
and skeletal muscle…………………………………………………………134 
Summary ….….……….…..………………………………..…….…………134 
Results and discussion.………………………………………..…..……….135 
 
  Bibliography………..…………………………..……………………...…………….144 
vi	  
List of Tables 
 
Table 2.1. Hdac3Wnt1NCKO mice exhibit perinatallethality.………………………….48 
 Table 2.2. Late gestation and perinatal craniofacial abnormalities in 
Hdac3Wnt1NCKO mice……………….………………………………………………..….49 
Table 2.3. Quantitative RT-PCR primer sequences..…………………………..….50 
    
 Table 3.1. Late gestation cardiovascular and thymic abnormalities in 
 Hdac3Wnt1NCKO embryos………...…….………………………………………………91 
Table 3.2. Hdac3Pax3NCKO die by P1..………………......……………………………92 
 Table 3.3. Late gestation cardiovascular and thymic abnormalities observed in   
Hdac3Pax3NCKO embryos recapitulate those observed using Wnt1-Cre…...…….93 
 
Table A.1. Genes differentially expressed in 6 week old (normal diet) Mck-Cre; 
Hdac3f/f versus Hdac3f/f hearts..…………………..…………………….……….….137 
vii	  
List of Figures 
 
Figure 1.1. Hdac3 functions in cardiomyocytes vary during cardiac development  
and postnatal homeostasis………………………………………………………..… 20 
Figure 1.2. Neural crest cell developmental potential is organized along the  
rostro-caudal axis……………………………………………………………………...22 
 
Figure 2.1. Deletion of Hdac3 in neural crest results in cranial hypoplasia at  
E10.5…………………………………………………………………………………... 53 
Figure 2.2. Craniofacial abnormalities in Hdac3Wnt1NCKO mice………………..…. 55 
Figure 2.3. Deletion of Hdac3 with Pax3Cre recapitulates the craniofacial 
abnormalities observed using Wnt1-Cre…………………………………………….57 
Figure 2.4. Hdac3Wnt1NCKO embryos exhibit defects in craniofacial bone due to 
dysregulation of important regulators of ossification……………………………… 59 
Figure 2.5. The loss of Hdac3 causes hypoplasia of neural crest-derived dental 
mesenchyme…………………………………………………………………………...61 
Figure 2.6. Cell cycle dysregulation and increased apoptosis underlie cleft palate 
in Hdac3Wnt1NCKO mice. ……………………………………………………………….63 
 Figure 2.7. Loss of p21 does not rescue craniofacial abnormalities in  
Hdac3Wnt1NCKO mutants……………………………………………………………..…65 
Figure 2.8. Bmp4 and downstream targets are dysregulated in Hdac3Wnt1NCKO  
cranial mesenchyme…………………………………………………………………..67 
 
Figure 3.1. Wnt1-Cre efficiently deletes Hdac3 in the pharyngeal arch  
mesenchyme,  conotruncal cushions and adrenal medulla…………………….... 94 
Figure 3.2. Late gestation Hdac3Wnt1NCKO embryos exhibit severe cardiovascular  
abnormalities……………………...………………………………………………...….96 
Figure 3.3. Cardiac abnormalities in late gestation Hdac3Pax3NCKO embryos.....98 
Figure 3.4. Hdac3Wnt1NCKO embryos exhibit thymic abnormalities…...………….100 
viii	  
Figure 3.5. Peripheral neurogenesis occurs normally in the absence of neural  
crest expression of Hdac3…………………………………………………………..102 
Figure 3.6. Chromaffin cells of the adrenal medulla develop normally in the  
absence of Hdac3. ……………………………………...………………………….. 104 
Figure 3.7. Hdac3Wnt1NCKO embryos display deficiencies in aortic arch artery  
smooth muscle at E11.5……………………………………………………………..106 
Figure 3.8. Hdac3Wnt1NCKO pharyngeal arches display decreased expression of  
the smooth muscle marker Sm22α in the aortic arch arteries at E11.5………..109 
Figure 3.9. Hdac3-deficient neural crest cells demonstrate a cell autonomous  
defect in smooth muscle differentiation. ……………………………………….….111 
Figure 3.10. Expression of the Notch ligand Jagged1, a critical regulator of  
smooth muscle differentiation in the aortic arch arteries, is dysregulated in  
Hdac3Wnt1NCKO arches at E11.5………………………...…………………………...113 
Figure 3.11. Overexpression of the notch intracellular domain partially restores  
smooth muscle in developing aortic arch arteries………………………………...115 
 
Figure 4.1. Model of Hdac3 regulation of craniofacial development……….…...130 
Figure 4.2. Model of Hdac3 regulation of cardiac outflow tract development….132 
 
Figure A.1. Efficient postnatal deletion of Hdac3 In Mck-Cre; Hdac3f/f hearts…138 
Figure A.2. Mild alterations in Hdac3-deficient hearts on normal chow………..140 
Figure A.3. Dietary lipid overload induced severe cardiac defects in mice lacking 
cardiac Hdac3. …………………………………………………….…………..……..142 
	  1	  
Chapter 1. Introduction 
 
Summary 
Developmental biology is among the oldest and most well established 
fields in the basic biological sciences. From their earliest incursions into this field, 
developmental biologists have been concerned with a single fundamental 
question:  
 
How can a single cell give rise to the all of the cell types and structures that 
comprise a complex organism? 
 
In much the same way that this single cell, the zygote, divides before 
giving rise to the rich diversity of cell types, the multitude of tissues, and the 
intertwined organ systems that comprise a multicellular organism, the field of 
developmental biology has itself divided before giving rise to new applications 
and entirely new areas of study, which are similarly intertwined. This field has 
been roughly subdivided into the studies of the growth and survival of cells, the 
specification and differentiation of cells, and morphogenesis of complex 
structures and organ systems. Indeed, the realization that development consists 
of these distinct but coordinated core processes was itself a critical advancement 
in the field. 
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Recent efforts in developmental biology have focused on understanding 
the molecular mechanisms underpinning these core developmental processes. 
Our burgeoning molecular understanding of these processes has not only helped 
us make inroads into answering developmental biologyʼs most fundamental 
question, but it has profoundly influenced the study and categorization of 
congenital diseases in humans, as well as our understanding of the pathogenesis 
of certain adult disease states. Furthermore, elucidation of the molecular 
foundations of developmental biology has been a guiding force directing inroads 
into the nascent field of regenerative medicine. 
At the heart of any molecular understanding of developmental processes 
lies the biology of the progenitor cell. It is impossible to understand how an organ 
develops and is remodeled in utero or how a tissue can be engineered and 
manipulated ex vivo without first understanding the factors directing the behavior 
of individual progenitor cells. This introductory chapter focuses on our increasing 
understanding of how progenitor cell behavior is regulated at the molecular level, 
and, in particular, at the level of the transcriptome.  Transcriptional regulation in 
progenitor cells is discussed in the specific context of murine neural crest cell 
biology. 
 
Extrinsic and intrinsic regulation of progenitor cell behavior 
The central dogma of gene expression states that a cellʼs transcriptome is 
determined by the primary sequence of DNA that comprises its genome. 
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However, this dogma lies at odds with the basic premise of developmental 
biology, in which different progenitor cells, each possessing the same genomic 
sequence, diversify and exhibit vastly different transcriptional profiles.  
As has become clear from molecular investigations into progenitor cell 
biology, external stimuli play an enormous role in influencing each progenitor 
cellʼs transcriptome, identity, and characteristics. For instance, the Notch 
signaling cascade, a direct cell-cell communication pathway, is a classical 
initiator of cellular differentiation in multiple developmental contexts (Andersson 
et al., 2011). Progenitor cells primed to receive Notch signals undergo 
transcriptional changes in response to Notch stimulation; these changes are 
mediated by the canonical downstream effector molecule of Notch signaling, the 
transcription factor NICD (Andersson et al., 2011). Similarly, the canonical Wnt 
signaling pathway, a paracrine signaling modality, has been shown in multiple 
settings to be critical for regulating the expansion of progenitor cell populations, 
again through a process mediated by nuclear translocation of a downstream 
effector molecule/transcription factor, ß-catenin (Klaus and Birchmeier, 2008). To 
be sure, numerous other signaling pathways and environmental stimuli have 
been shown to regulate countless aspects of progenitor cell behavior in many 
developmental processes. The influence of such external stimuli comprises a 
crucial, extrinsic level of regulation over the progenitor cell transcriptome, and 
offers insight into how cells with identical genomes can exhibit phenotypic 
differences. 
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However, despite their obvious importance, environmental triggers cannot 
account for all aspects of progenitor cell behavior. From the earliest 
transplantation studies, it has been appreciated that not all progenitor cells are 
equal; for instance, a neuronal progenitor cell will not differentiate into a 
cardiomyocyte if introduced into primary heart field, even if exposed to all of the 
environmental cues that normally drive cardiomyocyte differentiation. Clearly, 
there are additional levels of regulation at play – cell intrinsic processes that 
define a progenitor cellʼs competency to respond to specific external stimuli, as 
well as its ability to propagate information from such stimuli to its progeny, even 
after the stimulus is withdrawn.  Many of these intrinsic processes fall into the 
realm of epigenetics. 
 
Histone deacetylases and epigenetic regulation of gene 
expression 
 The field of epigenetics is comprised of the study of factors that stably 
affect transcription in a cell and its progeny without altering the sequence of DNA. 
Such factors can include long-lasting changes to the structure of chromatin that 
affect transcription at specific loci. In the operational definition of epigenetics 
proposed by Berger et al., epigenetic processes begin with an epigenator – a 
signal, from either environmental or intracellular origin that results in activation of 
an epigenetic initiator (Berger et al., 2009). These initiators are responsible for 
translating a signal from the epigenator into an alteration to chromatin structure 
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or accessibility. Finally, this chromatin alteration must be maintained by an 
epigenetic maintainer. This maintainer confers longevity and heritability to 
chromatin alterations even in the absence of continued stimuli from the 
epigenator.  
 Classic epigenetic maintainers include covalent modifications to either 
DNA itself or to histone proteins. Histone modifications, including histone tail 
methylation or acetylation, affect the structure of chromatin, thereby affecting the 
ability of transcription factors and other nuclear proteins to bind to promoter or 
enhancer regions. These modifications persist through DNA replication, and 
thereby confer stability through multiple cell divisions. 
 Acetylation occurs on at least 12 different lysines in the H3 and H4 histone 
proteins (Wang et al., 2008). Histone tail acetylation is generally associated with 
transcriptionally active chromatin, as characterized by RNA Polymerase II binding 
(Wang et al., 2009). Negatively charged acetyl groups repel DNA from histone 
proteins, creating a ʻrelaxed,ʼ euchromatic state, disrupting higher order 
chromatin structures, and permitting access to transcription factors and RNA 
Polymerase II (Wade et al., 1997). In a second mechanism by which histone 
acetylation status affects transcription, acetylated lysines serve as a binding 
substrate for bromodomain-containing transcription factors, resulting in RNA 
Polymerase II recruitment (LeRoy et al., 2008). Histone tail acetylation is tightly 
regulated by the antagonistic actions of histone acetyltransferases, such as 
p300, and histone deacetylases (Hdacs).  
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 Mammals express 11 ʻclassicʼ Hdac proteins, characterized by a highly 
conserved deacetylase domain. The canonical role of the aptly named Hdacs is 
to deacetylate histone tails. As such, Hdacs are viewed primarily as 
transcriptional repressors (Haberland et al., 2009b). These 11 proteins are 
subdivided into four classes based on homology (Haberland et al., 2009b).  The 
class I Hdacs - Hdac1, Hdac2, Hdac3 and Hdac8 - are important regulators of 
transcription, via chromatin-mediated transcriptional repression and, in some 
cases, via direct deacetylation of key transcriptional regulators (Haberland et al., 
2009b, Haberland et al., 2009a, LeBoeuf et al., 2010).  Hdac enzymatic activity is 
dependent on their association with large repressor complexes, such as the 
NuRD, CoREST or Sin3 complexes, which interact with Hdacs 1 and 2, and the 
NCoR and/or SMRT repressor complexes, which interact with Hdac3 (Yang and 
Seto, 2008). Hdacs do not possess intrinsic DNA binding ability, and are targeted 
to specific genomic loci through their interaction with corepressors, transcription 
factors and nuclear receptors (Yang and Seto, 2003).  
Deletion studies of individual class I Hdacs have revealed highly specific, 
non-redundant roles in various mammalian cell lineages. For instance, despite 
widespread expression, global deletion of Hdac2 results predominantly in cardiac 
abnormalities, while global deletion of Hdac8 solely affects patterning of the 
anterior calvarium and viscerocranium (Trivedi et al., 2007, Haberland et al., 
2009a). It was initially somewhat surprising that deletion of these global 
modulators of gene expression lead to dysregulation of specific pathways, rather 
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than to non-specific, ectopic upregulation of transcription. Perhaps equally 
surprisingly, tissue specific deletion studies have also revealed that an individual 
Hdac can mediate completely different processes either in different tissues or 
under different environmental conditions within the same tissue. The many roles 
played by class I Hdacs during development typify this tissue- and context-
dependency of Hdac function. 
 
Class I Hdacs in development 
Many epigenetic initiators, including class I Hdacs, have been shown to 
modulate transcription during development by linking the external environment 
encountered by progenitor cells to heritable changes in gene expression. Class I 
Hdacs are widely expressed during mammalian development and play very 
specific roles in both early developmental processes as well as later stages of 
embryogenesis. Global deletion of Hdac1 or Hdac3 results in early embryonic 
lethality, and therefore many of the approaches used to study the role of class I 
Hdacs in development have made use of Cre recombinase, driven under the 
control of tissue-specific promoters, to excise floxed alleles of Hdac genes	  
(Montgomery et al., 2007, Knutson et al., 2008). 
Conditional deletion studies have revealed that Hdac1 and Hdac2 are 
functionally redundant in many tissues, and tissue-specific compound deletion of 
both results abnormalities in a variety of systems. For instance, deletion of Hdac1 
and Hdac2 in embryonic epidermal progenitor cells results in impaired 
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specification of hair follicles and decreased epidermal stratification (LeBoeuf et 
al., 2010). Hdac1 and Hdac2 regulate epidermal development by working 
cooperatively with p63 and by directly deacetylating p53 in order to repress cell 
cycle inhibitors (LeBoeuf et al., 2010). Conditional deletion of Hdac1 and 2 in the 
developing nervous system has revealed critical, redundant roles in neuronal 
differentiation, oligodendrocyte differentiation, and myelination (Montgomery et 
al., 2009, Ye et al., 2009, Jacob et al., 2011). In the heart, Hdac1 and 2 act 
redundantly to regulate proliferation and contractility of developing 
cardiomyocytes. Additionally, Hdac2 is important in mediating the adult heartʼs 
hyertrophic response to pressure overload, in part by repressing the regulatory 
enzyme Inpp5f (Trivedi et al., 2007, Zhu et al., 2009). 
 
Hdac3 as a unique class I Hdac 
 Hdac3 is a 49 kilodalton class I Hdac most similar in homology to Hdac8 
(Haberland et al., 2009b). However, Hdac3 is unique among class I Hdacs in that 
it associates with NCoR or SMRT in a repressor complex, which is required for its 
catalytic activity (Guenther et al., 2001). Global deletion of Hdac3 in the mouse 
results in lethality at the gastrulation stage (Knutson et al., 2008). Hdac3 has 
been shown to regulate a variety of cellular processes, which are highly 
dependent on the type of tissue under investigation, as well as factors such as 
the nutritional state or developmental stage of the tissue. For instance, Hdac3 
has been shown to mediate differentiation in osteoblast and myocyte precursors 
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in vitro (Schroeder et al., 2004, Zeng et al., 2006); Hdac3 has been shown to 
regulate cell cycle progression in cell lines and cardiomyocytes (Li et al., 2006, 
Bhaskara et al., 2008, Montgomery et al., 2008, Knutson et al., 2008, Trivedi et 
al., 2008); Hdac3 also plays important roles in metabolic regulation in multiple 
tissues, including the heart, through its action as a transcriptional repressor 
(Montgomery et al., 2008, Sun et al., 2011, Knutson et al., 2008, Alenghat et al., 
2008). 
 As with other Hdacs, the functions of Hdac3 as a global agent of chromatin 
remodeling are determined by its genomic binding sites. Interestingly, ChIP-Seq 
studies have revealed that genomic localization of Hdac3 demonstrates very little 
overlap between different cell types, which is consistent with its broadly different 
functions in different tissues (Feng et al., 2011). Within each cell type, the Hdac3 
repressor complex is targeted to different genomic loci by transcription factors or 
nuclear receptors expressed in that cell (Feng et al., 2011). Hdac3 has been 
shown to interact directly with transcription factors such as Zfp521 in osteoblast 
precursors and PPARα in cardiomyocytes, in order to mediate its functions as a 
chromatin-remodeling enzyme (Hesse et al., 2010, Montgomery et al., 2008). 
Recent evidence suggests that as little as one factor may influence the majority 
of Hdac3 binding sites within a given tissue. In the liver, where Hdac3 is an 
important regulator of the circadian expression of metabolic genes, Hdac3 
binding specificity is predominantly determined by the nuclear receptor Rev-erbα 
(Feng et al., 2011). Rev-erbα directly associates with the Hdac3/NCoR complex 
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and is crucial for Hdac3-mediated transcriptional repression in hepatocytes. In 
fact, nearly all Hdac3 binding sites in hepatocytes, as determined by ChIP-Seq, 
overlap with Reverb-alpha binding sites. The abundance of Rev-erbα in 
hepatocytes is itself regulated by the metabolic state of the cell and circadian 
clock, resulting in a circadian oscillatory pattern to Rev-erbα nuclear localization. 
This periodicity results in a circadian pattern to Hdac3 genomic localization and 
function in the liver, offering an example of a contextual specificity to the function 
of Hdac3 within one cell type (Feng et al., 2011). 
 Clearly the functions of Hdac3 within a given tissue can be regulated by the 
expression and availability of its specific interacting partners within that tissue, as 
well as by related factors such as the nutritional state and zeitgeber time. 
However, little is known about how the functions of Hdac3 change within a 
specific tissue during other important biological transitions, including during 
organogenesis. 
 
Hdac3 in cardiac development and homeostasis 
 The study of Hdac3 in the heart provides an example of the diverse, 
context-dependent functions of this important regulatory molecule from early 
development to adult homeostasis. Cardiac development is characterized by the 
gradual lineage restriction of multiple progenitor cell populations, a process tightly 
linked to the emergence of a three-dimensional organ of progressively increasing 
morphological complexity. In normal cardiac development, mesodermally-derived 
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bipotent myocardial progenitor cells in the cardiac crescent undergo progressive 
lineage restriction, ultimately giving rise to either vascular smooth muscle 
precursors or myocardial progenitor cells (Epstein, 2010). Myocardial progenitor 
cells further differentiate, giving rise to immature cardiomyotytes, as well as other 
specialized cardiac cell types. These immature cardiomyocytes form a 
spontaneously beating single-chambered tube, which begins to circulate blood 
into the developing vascular network of the embryo. As this primitive heart tube 
beats, it loops upon itself, forming a two-chambered organ with a single atrium 
and ventricle, populated by phenotypically distinct atrial and ventricular myocytes. 
These processes occur in parallel with development of the outflow tract, 
discussed in detail in Chapter 3. Emybronic ventricular myocytes lack the 
plasticity of myocardial progenitor cells but differ from adult cardiomyocytes in a 
number of regards. Embryonic cardiomyocytes express different contractile 
proteins than their adult counterparts, and exhibit high proliferative potential. As 
the two-chambered heart grows, driven by myocyte proliferation, the single 
ventricular chamber is septated, a process dependent on neural crest cells 
(further discussed in Chapter 3). In late gestation and early in the perinatal 
period, cardiomyocytes mature, a process characterized by alterations to their 
mechanical and electrophysiological properties and their decreased proliferative 
and regenerative potential (Porrello et al., 2011). 
 Hdac3 acts at multiple stages in the transition from bipotent myocardial 
progenitors to embryonic and, ultimately, adult cardiomyocytes. Unpublished data 
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generated by Trivedi et al. in the Epstein lab shows that deletion of Hdac3 at 
embryonic day 8.5 (E8.5) in biopotent myocardial progenitor cells results in 
severe myocardial thinning and lethality by E16.5. These cardiac abnormalities 
arise due to cell cycle arrest and decreased proliferation of embryonic 
cardiomyocytes. This cell cycle arrest is accompanied by upregulation of the cell 
cycle inhibitor p21 (encoded by the Cdkn1a gene). Preliminary results suggest 
that heterozygous deletion of Cdkn1a in mutant embryos partially rescues the 
early cardiac lethality, with a small number of mutants surviving until birth. Hdac3 
has previously been shown to inhibit Cdkn1a transcription by directly binding to 
its promoter (Wilson et al., 2008); derepression of Cdkn1a in the absence of 
Hdac3 may therefore play a critical role in mediating the lethality following early 
cardiac deletion of Hdac3. 
 In addition to derepression of Cdkn1a, loss of Hdac3 in these mice leads to 
premature expression of markers of differentiated cardiomyocytes in vivo, and 
deletion of Hdac3 in cultured E8.5 myocytes leads to precocious differentiation 
and spontaneous beating in vitro. Preliminary data from chromatin 
immunoprecipitation experiments has revealed that Hdac3 directly binds to the 
promoter regions of cardiac-specific genes in E8.5 hearts, suggesting that it may 
serve as a direct repressor of cardiomyocyte differentiation in bipotent myocardial 
progenitor cells. Overall, these results suggest that Hdac3 directly represses 
mediators of myocardial differentiation as well as the cell cycle inhibitor p21; 
following early deletion of Hdac3, the myocardial progenitor cells pool is therefore 
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depleted via a combination of premature differentiation and cell cycle arrest, 
leading to severe cardiac abnormalities later in gestation. 
 A study by Olson and colleagues has shown that deletion of Hdac3 slightly 
later in cardiac development, at E9.5 using αMHC-Cre, allows for the completion 
of embryogenesis. αMHC-Cre mediates recombination in differentiated 
cardiomyocytes, rather than bipotent precursors. αMHC-Cre; Hdac3f/f mice are 
viable until two months of age; however, when fed a normal diet, these mice 
undergo cardiac hypertrophy at 4 weeks of age, which progresses to severe 
heart failure, culminating in lethality. This hypertrophy is characterized by 
myocardial lipid accumulation and fibrosis. The authors suggest that, following 
midgestational deletion of Hdac3, positive regulators of fatty acid uptake are 
derepressed, leading to progressive accumulation of lipid in the myocardium and 
eventual cardiac dysfunction and death. 
 In a collaborative effort with the Lazar lab, we have demonstrated that 
deletion of Hdac3 in perinatal myocytes - as opposed to bipotent progenitor cells 
or embryonic ventricular myocytes – results in dysregulation of a vastly different 
subset of genes than those dysregulated following mid-gestational deletion (Sun 
et al., 2011). In this study, mice lacking cardiac expression of Hdac3 show 
dysregulation of genes involved in the mitochondrial response to lipid overload. 
They exhibit no decrease in viability on a normal diet; however, when placed on a 
high fat diet, they exhibit severe cardiac defects leading to death. These data are 
summarized in the Appendix. These contrasting conditional deletion studies in 
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which Hdac3 has been deleted in the heart during midgestation versus in the 
perinatal period demonstrate that Hdac3 plays distinct roles in metabolic 
regulation at embryonic versus postnatal timepoints; furthermore, the time point 
at which Hdac3 is deleted in cardiomyocytes portends the long-term 
transcriptional perturbations that persist into adulthood.  
 Overall, these cardiac studies have revealed multiple roles for Hdac3 within 
a single cell lineage; Hdac3 inhibits differentiation down the cardiomyocyte 
lineage in bipotent myocardial precursors, represses genes involved in lipid 
metabolism in embryonic myocytes, and regulates different genes involved in the 
response to lipid overload in postnatal cardiomyocytes (Figure 1.1). Based on its 
roles in mediating developmental processes as well as cellular responses to 
environmental stimuli in the heart, Hdac3 is an attractive candidate epigenetic 
initiator that could integrate input from exogenous cues and regulate important 
developmental processes in a stage- and lineage-specific manner in other 
multipotent progenitor cells under complex regulation from external stimuli. 
 
Neural crest development 
 Neural crest cells comprise a transient embryonic progenitor cell 
population, specific to vertebrates, that provides a useful model for studying 
progenitor cell specification, migration and differentiation in the context of the 
development of multiple tissues and organ systems. Neural crest cells are 
derived from ectoderm and are specified at the dorsal neural tube at E8.5 in the 
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mouse. They subsequently undergo epithelial to mesenchymal transformation 
(EMT), delaminate from the neural tube and migrate throughout the embryo. 
They ultimately give rise to transient embryonic structures including the 
mesenchyme of the pharyngeal arches, as well as structures that persist in the 
adult vertebrate, including much of the smooth muscle of the cardiac outflow 
tract, much of the bone, cartilage and connective tissue of the head and face, 
neurons and support cells of the peripheral nervous system, and the chromaffin 
cells of the adrenal medulla (Figure 1.2). 
 Neural crest cells develop in a dynamic milieu, under the influence of 
environmental cues that regulate many aspects of their behavior. Though little is 
known about the signals that direct the specification of murine neural crest cells, 
environmental cues that drive neural crest migration, survival and differentiation 
in the mouse are well understood (Sauka-Spengler and Bronner-Fraser, 2008). 
Changes to the extracellular matrix help to initiate EMT, while ephrin and 
semaphorin-neuropilin signaling from surrounding cells have been implicated in 
neural crest cell migration through the somitic mesoderm (Sauka-Spengler and 
Bronner-Fraser, 2008, Davy et al., 2004, Gammill et al., 2007). As well, 
numerous signals encountered by both migrating and postmigratory neural crest 
cells direct their survival and differentiation (discussed further in Chapter 2 and 
Chapter 3). While much is now known about the signaling modalities that 
influence murine neural crest cell behavior, we are only beginning to understand 
how neural crest cells are able to synthesize these signals into heritable changes 
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in gene expression, and how individual neural crest cells initially become 
competent to respond to these exogenous cues. 
 
Epigenetic regulation of neural crest development  
 Neural crest cells are characterized by enormous developmental plasticity. 
However, it has long been appreciated that, from very early stages of neural crest 
development, there is in-equivalency between certain neural crest cells. Studies 
in which quail neural crest cells were transplanted into chick embryos have 
revealed the remarkable degree to which neural crest cells from one region along 
the rostro-caudal axis of the embryo can contribute to derivatives of another 
region - with some exceptions. Among the exceptions uncovered by Le Douarin 
and colleagues in a classic series of experiments; neural crest from the vagal 
region, which normally contributes to rostral elements of the enteric nervous 
system, was transplanted into the adrenomedullary trunk crest region, which 
normally gives rise to the adrenal medulla, sympathetic ganglia and the enteric 
plexi of the distal bowel. In this study, vagal neural crest cells were able to 
contribute to all derivatives of the adrenomedullary crest, with the exception of 
the distal enteric nervous system, to which they were unable to migrate (Le 
Douarin et al., 1975) . This limit on vagal trunk neural crest plasticity suggests 
that, in addition to being subject to external influences on their development, 
undifferentiated neural crest cells are subject to an intrinsic level of regulation. 
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Recent work has focused on understanding the nature of this intrinsic regulation 
of neural crest cell behavior.  
Neural crest migration is regulated by the expression of transcription 
factors such as Sox10 and Ret in response to environmental cues. Mutations in 
these genes have been implicated in Hirschprungʼs disease in humans, in which 
failure of neural crest cells to migrate to the distal gut and differentiate into enteric 
ganglia leads to defects in colonic motility. Recently, Aebp2, a targeting protein 
for the Polycomb Repression Complex 2 (a regulatory complex involved in 
transcriptional regulation via histone methylation), was shown to regulate the 
expression of several transcription factors that mediate neural crest cell 
migration. Mice haploinsufficient for Aebp2 demonstrate aganglionic megacolon, 
due to failure of neural crest cells to migrate to the distal enteric nervous system 
(Kim et al., 2011). The migration of neural crest cells into the distal gut is a 
process that, as early as 1975, was hypothesized by LeDourain and colleagues 
to be under cell intrinsic regulation; this study of an important chromatin 
remodeling complex has now shown that it is indeed regulated at an epigenetic 
level. 
 Additional attempts to determine which factors underlie intrinsic regulation 
of neural crest first focused on genes such as Hox family members, which have 
been shown to restrict cranial neural crest cell plasticity during skull 
morphogenesis (Hunt et al., 1991). More recently, as the field has moved 
towards studies of chromatin remodeling enzymes that regulate neural crest 
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development, one of the first such studies in the mouse revealed a connection 
between epigenetic processes and expression of Hox genes in craniofacial 
development. Olson and colleagues showed that Hdac8 normally restricts the 
expression of Hox family members in the anterior cranium during development, 
and that deletion of Hdac8 leads to ectopic Hox gene activation (Haberland et al., 
2009a). They further demonstrated that global deletion of Hdac8, as well as 
tissue specific deletion in neural crest, results in calvarial instability, leading to 
perinatal lethality (Haberland et al., 2009a). 
Transcriptional regulation via chromatin remodeling complexes has thus 
far been implicated in a limited number of aspects of neural crest development. 
Identifying additional chromatin remodeling enzymes that control other aspects of 
neural crest development - and deciphering the transcriptional networks that they 
regulate - will be a fruitful and important area of research as we seek to 
understand how progenitor cells are regulated at the epigenetic level. 
 
Conclusions 
An emerging body of work has implicated chromatin-modifying enzymes in 
the regulation of important processes and transitions during the development of 
multiple progenitor cell populations, including neural crest. Class I Hdacs have 
been recognized as important regulatory enzymes in many developmental 
contexts; Hdac3 in particular has been shown to regulate developmental 
processes in a growing number of organ systems, and offers an appealing 
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candidate for further investigation into the intrinsic regulation of neural crest 
development.
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Figure 1.1 
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Figure 1.1. Hdac3 functions in cardiomyocytes vary during cardiac 
development and postnatal homeostasis. A schematic diagram showing the 
different functions of Hdac3 in bipotential myogenic precursors, embryonic 
ventricular myocytes and perinatal cardiomyocytes, as well as the classes of 
genes that are dysregulated in a persistent manner following loss of Hdac3.
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Figure 1.2 
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Figure 1.2. Neural crest cell developmental potential is organized along the 
rostro-caudal axis. A gross image of an E9.5 embryo under direct fluorescence 
in which neural crest cells and their derivatives have been genetically labeled 
using Wnt1-Cre and the Z/EG GFP reporter. Labels denote the derivatives of 
neural crest cells originating from each region of the dorsal neural tube. 
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Chapter 2. Hdac3-mediated repression of Bmp4 in 
neural crest cells regulates murine craniofacial 
development 
 
Summary 
Craniofacial development is characterized by reciprocal interactions 
between neural crest cells and neighboring cell populations of ectodermal, 
endodermal and mesodermal origin. Various modalities of cell-cell 
communication, such as Bmp signaling, play critical roles in coordinating the 
development of cranial structures, by modulating the growth, survival, and 
differentiation of neural crest cells. However, the regulation of these signaling 
pathways, particularly at the epigenetic level, remains poorly understood. In this 
chapter I describe the role of Hdac3 in regulating important signaling pathways 
and transcriptional networks in craniofacial development. 
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Introduction 
 Vertebrates are unique among metazoans in their reliance on neural crest 
cells to form a wide array of structures in the head. These neural crest-derived 
craniofacial structures are analogous to mesodermally- and ectodermally-derived 
structures in invertebrates (Gans and Northcutt, 1983). In midgestation in the 
mouse, neural crest cells populate the pharyngeal arches – a series of paired 
outpouchings that flank the developing pharynx, as well as the frontonasal 
prominence, an area that eventually gives rise to the nose and forehead. The first 
pharyngeal arch, which is the largest and most rostral of the arches, contains 
neural crest cells that will form structures in the face and neck (Alappat et al., 
2003). Driven by the proliferation and continued influx of migrating neural crest 
cells, two distinct outgrowths from the first arch, known as the maxillary and 
mandibular prominences, grow dorso-ventrally and flank the developing 
oropharynx, eventually fusing at the ventral midline in what becomes the face. 
Failure of neural crest cells to migrate or proliferate appropriately can result in 
hypoplasia of these structures and the absence of fusion, which can manifest as 
abnormal facies and clefting (Ito et al., 2003, Vallejo-Illarramendi et al., 2009).  
While initially dependent on the tightly-regulated growth of undifferentiated 
neural crest cells in the prominences, craniofacial development is also reliant on 
the ability of neural crest cells to differentiate into bone, cartilage, connective 
tissue, dental pulp and neurons that populate the mature face and skull. In the 
primordial environment of the growing pharyngeal arches, neural crest cells are 
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characterized by enormous developmental plasticity (Couly et al., 1993). In the 
setting of such plasticity, the ability of neural crest cells to contribute to such 
varied cell types is largely dependent on their exposure to environmental cues 
from surrounding cells of both neural crest and non-neural crest origin (Le 
Douarin et al., 2004). Indeed, as discussed in Chapter 1, both the survival and 
differentiation of neural crest cells are under tight regulation by multiple signaling 
modalities. 
Murine genetics have proven invaluable in deciphering the exogenous 
signals that coordinate the growth and differentiation of cranial neural crest cells. 
For instance, models of conditional deletion and overexpression of Bmp4 have 
revealed roles for this signaling molecule in various aspects of craniofacial 
development. Bmp4 is primarily expressed by epithelial structures in the 
developing face, which signal to neural crest-derived mesenchyme to mediate 
processes such as palatogenesis and tooth development (Zhang et al., 2002, 
Mitsiadis et al., 2010). Interestingly, both abrogation and ectopic activation of 
BMP signaling lead to cell cycle dysregulation, cleft palate and tooth 
abnormalities, suggesting that this signaling pathway is subject to multiple levels 
of regulation in neural crest development (He et al., 2010). 
While the correct spatial and temporal expression of signaling molecules is 
critical for normal craniofacial morphogenesis, little is known about how the 
signaling pathways involved in this process are regulated at the epigenetic level. 
Using in vivo and in vitro models, I show in this chapter that the class I histone 
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deacetylase Hdac3 regulates important genetic programs and signaling pathways 
involved in murine craniofacial development. Genetic deletion of Hdac3 in neural 
crest results in microcephaly, cleft palate, ossification defects and other 
craniofacial abnormalities in late gestation. Consistent with these observations, 
we observe dysregulation of mediators of craniofacial development in 
midgestation following loss of Hdac3, including transcription factors belonging to 
the Msx and Tbx families. We show that this aberrant gene expression is 
mediated, in part, by derepression of Bmp4 in neural crest. These results suggest 
that Hdac3-mediated repression of Bmp4 plays a critical role in craniofacial 
development. 
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Results 
 
Hdac3 is expressed during embryogenesis and is efficiently deleted in 
premigratory neural crest cells by Wnt1-Cre 
 Immunohistochemistry of staged embryos demonstrates that Hdac3 is 
widely expressed at E10.5, including in the dorsal neural tube, where neural crest 
cells are specified before delaminating and migrating throughout the embryo  
(Figure 2.1 A). Hdac3 is also expressed by neural crest derivatives, including 
dorsal root ganglia (DRG) and cranial mesenchyme (Figure 2.1 A,B). 
 The Wnt1-Cre transgene is expressed by premigratory neural crest cells 
as early as E8.75 (Jiang et al., 2000). We used Wnt1-Cre and a floxed Hdac3 
allele (Hdac3f) to delete Hdac3 in premigratory neural crest cells and their 
derivatives, and we used the Z/EG reporter to lineage trace neural crest cells in 
both control and mutant embryos (Feng et al., 2011, Novak et al., 2000). In this 
lineage tracing strategy, Cre mediates a recombination event that results in the 
constitutive expression of GFP in all derivatives of Wnt1-Cre-expressing cells. 
Immunostaining for GFP reveales expression in the dorsal neural tube in both 
Wnt1-Cre; Hdac3f/f (termed Hdac3Wnt1NCKO); Z/EG and Wnt1-Cre; Z/EG control 
embryos (Figure 2.1 A). In E10.5 Hdac3Wnt1NCKO embryos, the GFP-positive cells 
in the dorsal neural tube show loss of Hdac3 protein, indicating efficient Cre-
mediated recombination in neural crest (Figure 2.1 A). Lineage tracing analysis 
further demonstrates that neural crest cells populate the DRG, pharyngeal arches 
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and cranial mesenchyme in E9.5 and E10.5 Hdac3Wnt1NCKO; Z/EG embryos, 
despite efficient deletion of Hdac3 in these tissues (Figure 2.1 A-C). 
Immunohistochemistry also reveals that Hdac3 deletion is specific to neural 
crest-derived mesenchyme, while expression is retained in ectoderm and 
endoderm (Figure 2.1 C). However, despite grossly intact neural crest cell 
specification and migration in the absence of Hdac3, marked hypoplasia of the 
neural crest-derived maxillary and mandibular prominences of the first 
pharyngeal arch is apparent by E10.5 in Hdac3Wnt1NCKO embryos (Figure 2.1 
C,D). 
 
Hdac3Wnt1NCKO embryos exhibit severe craniofacial abnormalities in late 
gestation, resulting in perinatal lethality 
Hdac3Wnt1NCKO embryos are found at expected Mendelian ratios in late 
gestation and are viable until birth (Table 2.1). However, these mice uniformly 
succumb at P0 (Table 2.1). Hdac3Wnt1NCKO mice are born with microcephaly, 
micrognathia, a shortened snout and eyelid closure defects, with preservation of 
body morphology (Figure 2.2 A). Optical projection tomography and histology of 
Hdac3Wnt1NCKO heads reveals cleft palate, which is also apparent in late gestation 
embryos (Figure 2.2 B,C). The palate defect is characterized by a large posterior 
cleft without additional facial clefting (Figure 2.2 B). Cleft palate is fatal in 
perinatal mice; afflicted pups are unable to generate suction and nurse, and 
subsequently die at P0 from dehydration and accumulation of air in the digestive 
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tract (Qiu et al., 1995, Condie et al., 1997). Consistent with these reports, 
Hdac3Wnt1NCKO pups are unable to feed, as evidenced by the lack of a milk spot 
(Figure 2.2 A). The gross craniofacial defects observed in Hdac3Wnt1NCKO mice 
are fully penetrant and are summarized in Table 2.2. We observed similar 
craniofacial abnormalties using a second neural crest driver, Pax3Cre (Engleka et 
al., 2005); these abnormalities are also evident both at P0 and in late gestation 
(Figure 2.3). 
 
Loss of Hdac3 leads to ossification defects in the calvarium and 
viscerocranium 
 In the adult vertebrate, osteoblasts are among the most abundant cell 
types generated by cranial neural crest. Neural crest-derived osteoblasts 
contribute to the bones of the face, the skull base and the entirety of the 
calvarium, with the exception of the parietal bone (Santagati and Rijli, 2003). 
Hdac3 has previously been implicated in multiple stages of osteoblast 
differentiation and maturation. In committed, undifferentiated osteoblasts that 
express the Osx-Cre transgene, deletion of Hdac3 leads to subtle abnormalities 
in calvarial osteoblast differentiation, and progressive abnormalities in trabecular 
bones that lead to perinatal runting, and death early in adulthood (Razidlo et al., 
2010). While these findings demonstrate a role for Hdac3 in promoting bone 
formation, in both perinatal osteoblasts and in the MC3T3 cell line, Hdac3 inhibits 
the pro-osteogenic effects of Runx2, suggesting that Hdac3 is playing an anti-
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osteogenic role in a slightly later stage of bone development (Schroeder et al., 
2004, Hesse et al., 2010). In more mature osteoblasts, marked by RANKL 
expression, Hdac3 inhibits the anti-osteogenic effects of Runx2, resulting in a net 
pro-osteogenic role once again (Hesse et al., 2010). 
Consistent with a pro-osteogenic role for Hdac3 in the earliest stages of 
bone development, Hdac3Wnt1NCKO mice - in which Hdac3 is deleted well before 
osteoblasts are specified (before the onset of Osx-Cre expression) - exhibit 
severe bone defects in the calvarium and viscerocranium.  Alcian blue/alizarin 
red staining of the late embryonic and perinatal heads reveales decreased 
ossification of the calvarium, particularly in the region of the frontal bone, where 
ossified bone is undetectable by alizarin red staining (Figure 2.4 A). The open 
frontal fontanel leads to hemorrhage in some newborn pups following parturition 
(Figure 2.2 B). The parietal bone develops normally in Hdac3Wnt1NCKO mutants, 
consistent with its mesodermal origin (Figure 2.2B). In mutant embryos, 
ossification abnormalities of the viscerocranium were also identified in the 
mandible, skull base and tympanic ring (Figure 2.4 A). 
Additional bone abnormalities in E17.5 mutant embryos are detected by 
Goldnerʼs trichrome staining. Neural crest-derived calvarial bones, including the 
frontal bone, are thin and show minimal mineralization (Figure 2.4B). Additionally, 
at variable penetrance, absence of ossification in the cribiform plate results in 
encephalocoele, in which the brain herniates into the nasal sinuses (Figure 2.4 
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B). The ossification defects observed in Hdac3Wnt1NCKO mice are summarized in 
Table 2.2. 
We used an ex vivo approach to identify important regulators of 
ossification that are dysregulated following the loss of Hdac3. We grew cranial 
mesenchyme isolated from mutant and littermate controls in culture and found 
that Runx2, a critical regulator of ossification, and alkaline phosphatase, a marker 
of differentiating bone, are significantly downregulated in mutant cultures (Figure 
2.4 C). We subsequently found that Runx2 expression in the developing 
calvarium and skull base is decreased in vivo at E12.5 (Figure 2.4 D). The Runx2 
expression domain is diminished in spite of the presence of large numbers of 
neural crest cells in these regions in the mutant (Figure 2.4 D). These results 
suggest that downregulation of Runx2 in neural crest cells is an important 
mechanism by which ossification defects develop in Hdac3Wnt1NCKO embryos. 
 
Abnormal odontogenesis in the absence of Hdac3 leads to dental 
hypoplasia 
 In tooth development, signals from the epithelium initiate condensation of 
neighboring neural crest cells at E11.5 (Chen et al., 2000). As epithelial cells 
invaginate, they envelop neural crest cells, which will eventually form the pulp of 
the tooth (Figure 2.5 A). The early stages of odontogenesis proceed normally in 
Hdac3Wnt1NCKO embryos, with tooth bud morphology at E15.5 appearing similar to 
littermate controls (Figure 2.5 A-D). However, expansion of the neural crest-
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derived mesenchyme does not occur between E15.5-E17.5, resulting in 
hypolastic teeth with the absence of normal pitting (Figure 2.5 E,F). The tooth 
bud hypoplasia in mutant embryos parallels the hypoplasia observed in other 
neural crest-derived structures in late gestation (Figure 2.2). 
 
Aberrant cell cycle regulation in Hdac3-deficient cranial mesenchyme 
leads to cleft palate and microcephaly 
 In order to determine the mechanism of cleft palate in Hdac3Wnt1NCKO 
embryos, we performed a histological analysis of staged control versus mutant 
embryos. In normal palatogenesis, the anterior palate (referred to as the primary 
palate) is formed by the initial fusion of the maxillary prominences with the 
frontonasal prominence. Hdac3Wnt1NCKO embryos exhibit posterior cleft palate, 
suggesting that secondary palatogenesis is disrupted (Figure 2.2 B). The 
posterior aspects of the hard palate (referred to as the secondary palate) are 
formed from two outgrowths of neural crest-derived mesenchyme that lie on 
either side of the stomodeum (primitive mouth). These outgrowths are referred to 
as the palatal shelves, and are detectable at E11.5 in the mouse (Figure 2.6 A). 
Between E11.5 and E13.5, the palatal shelves, driven by neural crest cell 
proliferation, expand towards the mandible (Figure 2.6 A,B). Between E13.5 and 
E14.5, the palatal shelves elevate relative to the tongue and fuse in the midline 
with the nasal septum (Figure 2.6 C). This newly formed structure subsequently 
ossifies, giving rise to the secondary palate.  
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 Disruption of any of the stages of secondary palatogenesis - palatal shelf 
formation, expansion, elevation, fusion or ossification – can lead to cleft palate in 
mice, and similar mechanisms can contribute to secondary cleft palate in humans 
(Richarte et al., 2007, Ito et al., 2003, Vallejo-Illarramendi et al., 2009, He et al., 
2011, Wu et al., 2008). Histological analysis of Hdac3Wnt1NCKO embryos reveals 
that the palatal shelves form appropriately but are hypoplastic at E12.5 (Figure 
2.6 E,F). Despite appropriate elevation of the medial aspect of the palatal shelves 
by E14.5, they do not meet at the midline (Figure 2.6 G). These results suggest 
that cleft palate results in Hdac3Wnt1NCKO embryos due to a failure of palatal shelf 
expansion. 
 Expansion of the palatal shelves is dependent on proliferation and survival 
of the neural crest cells that make up the palatal shelf mesenchyme (Ito et al., 
2003). In E12.5 control versus mutant palatal shelves that were matched for 
surrounding anatomical landmarks, we detected a significant increase in 
apoptosis and a trend towards decreased proliferation, as determined by Tunel 
and phospho-histone H3 staining, respectively (Figure 2.6 I). Increased Tunel 
staining is also visible throughout additional cranial neural crest-derived 
structures outside of the palatal shelf region, suggesting that hypoplasia of these 
structures is also mediated by increased apoptosis (Figure 2.6 I and data not 
shown). 
 To discern the nature of the cell cycle dysregulation in Hdac3Wnt1NCKO 
cranial mesenchyme, we performed expression profiling by quantitative RT-PCR 
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in the anterior cranial region of mutant embryos and littermate controls (Figure 
2.6 J). While Hdac3 expression in mutant tissue is significantly downregulated, 
expression of additional class I Hdacs is unchanged (Figure 2.6 K). Strikingly, the 
expression of multiple cell cycle regulators was found to be altered in 
Hdac3Wnt1NCKO cranial mesenchyme. Cdkn1a (p21), Trp52 (p53), Ccnd1c (p57), 
Ccnd1 (Cyclin D1), Ccnd3 (Cyclin D3), CcnG1 (Cyclin G1) and Cdk2 are 
significantly upregulated in the absence of Hdac3, while Cdkn2c (p18) expression 
is downregulated (Figure 2.6 L).  
 Hdac3 has previously been shown to directly repress the cell cycle 
inhibitor p21 in multiple tissues (Wilson et al., 2008, Trivedi et al., 2008). In order 
to determine whether the substantial upregulation of p21 observed in 
Hdac3Wnt1NCKO cranial mesenchyme could alone account for cleft palate and 
microcephaly in these embryos, we deleted Hdac3 in neural crest on a p21 null 
background (Deng et al., 1995). Homozygous p21-/- mice develop normally and 
are viable and fertile (Deng et al., 1995). We found that loss of p21 does not 
rescue the cleft palate and microcephaly observed in Hdac3Wnt1NCKO embryos, 
suggesting that dysregulation of additional cell cycle modulators contributes to 
altered regulation of neural crest expansion in Hdac3-deficient cranial neural 
crest cells and, ultimately, to cleft palate and craniofacial hypoplasia (Figure 2.7). 
 
The loss of Hdac3 results in dysregulation of core transcriptional networks 
that regulate craniofacial development 
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Multiple families of transcription factors have been implicated in neural 
crest cell cycle regulation in craniofacial development. We undertook a candidate 
approach to identify whether loss of Hdac3 results in misexpression of known 
regulators of cranial crest expansion and survival. Msx1 and Msx2 are expressed 
in the cranial mesenchyme, and are known to modulate the cell cycle during 
palatogenesis, viscerocranial morphogenesis, and tooth development (Alappat et 
al., 2003). We observed marked upregulation by quantitative RT-PCR of Msx1, 
Msx2 and Msx3, in E12.5 mutant cranial mesenchyme (Figure 2.8 A). Msx family 
members promote apoptosis in neural crest cells, and their upregulation is 
consistent with the cell cycle dysregulation and increased apoptosis in 
Hdac3Wnt1NCKO mice (Alappat et al., 2003). Interestingly, transgenic 
overexpression of Msx2 leads to cleft secondary palate, micrognathia, tooth 
hypoplasia and eyelid dysplasia due to increases in cell death, which 
phenocopies many aspects of the Hdac3Wnt1NCKO abnormalities (Winograd et al., 
1997).   
In addition to upregulation of Msx family members, we also observed 
significant upregulation of the Tbx family members Tbx2 and Tbx3 (Figure 2.8 A). 
Tbx2 and Tbx3, like Msx1 and Msx2, are normally expressed in neural crest-
derived cranial mesenchyme and are similarly important in cell cycle regulation 
during palatogenesis (Zirzow et al., 2009). Loss of Tbx2 or Tbx3 in craniofacial 
development leads to cleft palate due to excessive proliferation, and both 
proteins have been identified as inhibitors of the cell cycle in palatogenesis 
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(Zirzow et al., 2009). Overall, upregulation of these Msx and Tbx family members 
– known inhibitors of neural crest survival - is consistent with the increased 
apoptosis and cell cycle dysregulation observed in Hdac3Wnt1NCKO cranial 
mesenchyme, and the resultant craniofacial hypoplasia and cleft palate in mutant 
embryos. 
  
Increased expression of Bmp4, a critical regulator of craniofacial 
development, in Hdac3Wnt1NCKO cranial mesenchyme  
 Hdac3 is a global agent of gene repression and has previously been 
shown to directly regulate important transcriptional networks in multiple 
developmental contexts (Schroeder et al., 2004, Zeng et al., 2006). The 
upregulation of Msx and Tbx family members observed in Hdac3Wnt1NCKO 
embryos could therefore plausibly occur as a result of their direct transcriptional 
derepression in the absence of Hdac3. However, Msx and Tbx family members 
have also been implicated in a genetic pathway involving Bmp4, and have been 
identified as direct targets of Bmp4 signaling in craniofacial development (Bei and 
Maas, 1998, Lee et al., 2007). Bmp4 is expressed predominantly by epithelial 
cells, which signal directly to neural crest to regulate palatogenesis and tooth 
development (Mukhopadhyay et al., 2006, He et al., 2010, Mitsiadis et al., 2010). 
Gain of BMP signaling results in craniofacial abnormalities that partially 
phenocopy the abnormalities identified in Hdac3Wnt1NCKO embryos (He et al., 
2010). However, loss of BMP signaling also phenocopies aspects of these 
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phenotypes, albeit through different mechanisms (Baek et al., 2011, Mitsiadis et 
al., 2010). We detected significant upregulation of Bmp4 expression in the 
anterior cranial mesenchyme of E12.5 Hdac3Wnt1NCKO embryos, which is 
consistent with the increased apoptosis and the pattern of transcriptional 
dysregulation observed in mutant craniofacial mesenchyme  (Figure 2.8 A). 
In craniofacial development, Bmp4 expression is activated by Sonic 
Hedgehog signaling in an autoregulatory loop (Lan and Jiang, 2009, Zhang et al., 
2002). However, little is known about how Bmp4 expression is restricted in the 
neural crest. We observed upregulation of Bmp4 in conjunction with a small but 
statistically insignificant upregulation of Shh (Figure 2.8 A).  These observations 
are consistent with a model in which Hdac3 directly represses transcription at the 
Bmp4 locus, such that the loss of Hdac3 in neural crest leads to direct 
transcriptional derepression. 
Based on these findings, we hypothesized that altered Bmp4 expression 
in Hdac3-deficient neural crest could account, in part, for the gene expression 
profile and phenotypic abnormalities observed in Hdac3Wnt1NCKO embryos. We 
used an ex vivo approach to determine the importance of Bmp4 derepression in 
mediating the Msx2 upregulation observed in Hdac3-deficient cranial neural 
crest. We found that total loss of Hdac3 in E12.5 cultured anterior mesenchymal 
cells results in massive cell death (data not shown). Therefore, we induced partial 
knockdown of Hdac3 using shRNA, and examined the expression of Bmp4 and 
Msx2 in this tissue. We found that partial knockdown of Hdac3 results in a trend 
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towards Bmp4 upregulation, and statistically significant upregulation of Msx2 
(Figure 2.8 C). This upregulation of Msx2 is abolished by siRNA-mediated 
knockdown of Bmp4. These results are consistent with a model in which Hdac3 
regulates a Bmp4-Msx2 signaling pathway in cranial neural crest during 
craniofacial development. 
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Discussion 
At multiple stages of neural crest development, the growth and survival of 
neural crest cells comes under positive and negative regulation from surrounding 
cell types (Sauka-Spengler and Bronner-Fraser, 2008). The signaling molecule 
Bmp4 is an important mediator of neural crest apoptosis in both early and late 
stages of craniofacial morphogenesis. Delamination of cranial neural crest cells 
from the dorsal neural tube requires the programmed death of neural crest cells 
at specific levels (rhombomeres) along the rostro-caudal axis. In the chick, Bmp4 
is expressed specifically in these rhombomereic levels, both in neural crest cells 
themselves and in neighboring ectoderm (Graham et al., 1994). Bmp4 signaling 
upregulates Msx2 in order to mediate apoptosis in these populations of neural 
crest cells, allowing suriving cells from other rhombomeres to appropriately 
populate the developing face (Graham et al., 1994). The mechanism by which 
Bmp4 expression is restricted to particular rhombomeric levels is not known. 
Excessive Bmp4 signaling in the cranial neural crest in mouse has been shown 
to portend abnormal palatal shelf morphology, secondary cleft palate, and dental 
hypoplasia (He et al., 2010). These abnormalities are consistent with the 
phenotypes caused by Msx2 transgenic overexpression as well as many of the 
phenotypes observed in Hdac3Wnt1NCKO embryos  (Figure 2.1 C,D, Figure 2.2). It 
is therefore intriguing to speculate that Hdac3 could be required to restrict the 
expression of Bmp4 in rhombocephalic neural crest. Loss of Hdac3 would 
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therefore result in persistent upregulation of Bmp4 in cranial neural crest, leading 
to hypoplasia of craniofacial structures. 
Both increased and decreased Bmp4 activity in neural crest development 
lead to dysregulation of downstream Msx and Tbx transcription factors and 
severe craniofacial abnormalities (He et al., 2010, Bei and Maas, 1998). That 
craniofacial morphogenesis is so exquisitely sensitive to Bmp4 activity speaks to 
the importance of fine regulation of Bmp4 expression in neural crest 
development. Our study offers the first evidence of a chromatin remodeling 
enzyme playing a role in the regulation of Bmp4 expression. While our data 
demonstrate that Hdac3 is required to repress Bmp4 transcription, additional 
work is required to discern whether this transcriptional repression is mediated by 
direct Hdac3 binding at the Bmp4 locus, or whether this repression is mediated 
through intermediates (further discussed in Chapter 4).  
In this study we have also identified a distinct role for Hdac3 in promoting 
ossification of neural crest-derived bone. This finding is consistent with a pro-
ossification role for Hdac3 previously identified in committed osteblast 
precursors, although we have found that deletion of Hdac3 prior to commitment 
of osteoblasts results far more drastic deficiencies in bone development than 
deletion in committed precursors (Razidlo et al., 2010). The mechanism of a pro-
ossification role of Hdac3 has not previously been described. In addition to 
regulating the Bmp4-Msx pathway, it is likely that Hdac3 regulates a wide range 
of other downstream targets in neural crest. While dysregulation of the Bmp4-
	  42	  
Msx pathway is sufficient to explain many of the craniofacial defects of Hdac3 
mutant pups, it is unlikely to contribute to the ossification abnormalities. 
Paradoxically, deletion of Msx1 and Msx2 in neural crest leads to heterotopic 
bone formation, particulary in the frontal bone region, while Msx2 transgenic 
overexpression also results in ectopic bone formation (Roybal et al., 2010, Liu et 
al., 1995). This suggests that additional targets of Hdac3 are likely to underlie the 
ossification abnormalities in Hdac3Wnt1NCKO mice.  
Gene expression analysis of explanted tissue demonstrated that the 
critical regulator of ossification Runx2 is significantly downregulated in Hdac3-
deficient tissue. Hdac3 has not previously been shown to regulate Runx2 
expression. However, Hdac3 antagonizes the pro-osteogenic activity of Runx2 in 
perinatal osteoblast precursors, while antagonizing the anti-osteogenic activity of 
Runx2 in more mature osteoblasts (Schroeder et al., 2004, Hesse et al., 2010). 
These diverse roles played by Hdac3 in the regulation of Runx2 in osteogenesis 
are reminiscent of the varied functions of Hdac3 in cardiac development and 
homeostasis (discussed in Chapter 1). In both organ systems, Hdac3 mediates 
vastly different - even antagonistic - processes in different developmental stages 
of the same tissue. Determining how the role of Hdac3 is altered during the 
course of each tissueʼs development will be an interesting area of future 
investigation. 
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Materials and Methods  
 
Mice 
 Wnt1-Cre, Pax3Cre, Hdac3flox and Z/EG mice were maintained on mixed 
CD1/B6/129 genetic backgrounds, separated by 3-6 generations of incrossing 
from pure parental backgrounds (Jiang et al., 2000, Engleka et al., 2005, Feng et 
al., 2011, Novak et al., 2000). p21 null mice were on a pure 129 background 
(Deng et al., 1995). Mice were genotyped using previously described Cre-specific 
PCR primers (5ʼ-TGC CAC GAC CAA GTG ACA GC-3ʼ, 5ʼ-CCA GGT TAC GGA 
TAT AGT TCA TG-3ʼ) (Heidt and Black, 2005), and primers designed to 
distinguish between the control and floxed Hdac3 allele (5ʼ-GCA GTG GTG GTG 
AAT GGC TT-3ʼ, 5ʼ-CCT GTG TAA CGG GAG CAG AAC TC-3ʼ).  Genotyping for 
the Z/EG transgene was performed by X-Gal staining tail samples. Littermate 
embryos were analyzed in all experiments unless otherwise noted. The 
University of Pennsylvania Institutional Animal Care and Use Committee 
approved all animal protocols. 
 
Histology and immunohistochemistry 
These techniques were performed on paraformaldehyde-fixed, paraffin 
imbedded slides as previously described (High et al., 2008). Mutant and 
littermate control embryos were generated from Wnt1-Cre; Hdac3f/+; Z/EG, Wnt1-
Cre; Hdac3f/+ or Pax3Cre/+; Hdac3f/+ animals crossed to Hdac3f/+, Hdac3f/+; Z/EG 
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or Hdac3f/f animals, respectively. Embryos were dissected in cold PBS, fixed 
overnight in 2% paraformaldehyde, dehydrated into 100% ethanol, embedded in 
paraffin and sectioned.  H&E and Goldnerʼs trichrome staining were performed 
using standard procedures. Primary antibodies used for immunohistochemistry 
were anti-GFP goat polyclonal (Abcam AB6673, 1:100), anti-GFP rabbit 
polyclonal (Invitrogen A-11122, 1:200) and rabbit polyclonal anti-Hdac3 (Santa 
Cruz sc-11417x, 1:10). 
 All control versus mutant histological and immunohistochemical images 
were taken at the same exposure and contrast settings, using NIS Elements 
software. ImageJ software was used to merge images and for quantification of 
neurofilament and tyrosine hydroxylase staining intensity. In some cases, ImageJ 
was used to decrease image brightness, and this was performed identically in 
control and mutant images.  
Cell number, proliferation and apoptosis were quantified by manually 
counting nuclei, pHistone H3-, or Tunel-positive cells, respectively, in adjacent 
sections of the anatomically-defined palatal shelf region in a blinded manner. 
 
Optical projection tomography 
E10.5 embryos were fixed in 4% paraformaldehyde overnight. Embryos 
were bleached for 30 minutes in 5% H2O2 in PBST, digested in 10µg/mL 
proteinase K in PBST for 5 minutes and immunostained with mouse polyclonal 
Anti-2H3 (Iowa Hybridoma Bank, 1:100). An HRP Conjugated secondary 
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antibody and DAB substrate kit (Vector Laboratories) were used to visualize 
peripheral nerves.  
For OPT scanning, embryos were dehydrated into 100% methanol, 
embedded in 1% low-melt agarose, cleared overnight in 1:2 (v/v) benzyl alcohol 
and benzyl benzoate, and scanned using the Bioptonics OPT scanner (3001M) 
(Sharpe et al., 2002). Image stacks were reconstructed using OsiriX software. 
Image contrast was optimized to reveal peripheral nerve patterning. 
 
Alcian blue/alizarin red staining 
 Embryos and neonatal mice were fixed for 7 days in 90% ethanol for one 
week at 4°C. Samples were stained for 3-5 days at room temperature with Alcian 
blue solution (0.2mg/ml Alcian Blue, 80% ethanol, 3.5M acetic acid) to visualize 
cartilage, and then rehydrated with an ethanol/water gradient. Samples were then 
incubated with 1% KOH for 2, followed by incubation for 3 days with Alizarin Red 
solution (0.05mg/ml Alizarin Red S in 1% KOH) to visualize bone, followed by 3 
washes (2-3 hours each) in 1% KOH solution. 
 
Anterior cranial mesenchyme explant cultures 
 The anterior cranial mesenchyme of wild type CD1 embryos was 
dissected in sterile PBS supplemented with 1% penicillin/streptomycin (Gibco). 
Tissue was triturated in cold 0.25% trypsin (Gibco), incubated on ice for 5 
minutes, and then at 37°C for 10 mins on a nutator. 10% v/v FBS was used to 
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stop trypsination, cells were further triturated to a single cell suspension, spun at 
300x g for 5 minutes, resuspended in αMEM (Invitrogen A10490-01), filtered 
through a 40μm filter, and played in 6-well plates. After two hours, cells were 
transfected with 5nmol of total siRNA using 4 μL of Lipofectamine 2000 
(Invitrogen) per well in 600μL total volume of serum free αMEM and Optimem 
(Gibco). Control siRNA (D-001810), Hdac3 siRNA (L-043553), and Bmp4 siRNA 
(L-043095) were obtained from Thermo Scientific. After overnight transfection, 
media was replaced with serum-free αMEM and cells were grown for an 
additional 24 hours before being harvested for RNA isolation. 
 
RNA isolation, complementary DNA synthesis and quantitative RT-PCR 
 From explanted cranial mesenchyme, RNA was harvested in 1mL of Trizol 
(Invitrogen). Cells were sheared with trituration and by being passed twice 
through a 26 gauge needle. 
For E12.5 cranial mesenchyme expression profiling, Wnt1-Cre; Hdac3f/f 
and litermate Cre-negative control embryos were microdissected with tungsten 
needles in cold PBS. Samples were immediately immersed in 1mL Trizol and 
homogenized with a handheld homogenizer. Samples were passed twice through 
a 26 gauge needle to shear genomic DNA and incubated at room temperature for 
10 minutes. 100μL of BCP reagent (Molecular Research Center) was added to 
samples, which were mixed for 15s and spun in a microcentrifuge at 11.5k rmp 
for 15mins at 4°C. The aqueous phase was then combined with 600μL of 70% 
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ethanol. The sample was applied to a Qiagen RNeasy spin column, and 
subsequent kit steps, including on column DNAse I digestion, were followed. 
Total RNA was eluted in 50μL of RNAse free water (Qiagen), and evaporated 
down to a total volume of 15μL. Complementary DNA (cDNA) was synthesized 
according to kit instructions with the Superscript III system (Invitrogen). 
 Quantitative RT-PCR was performed in triplicate using Sybr Green 
(Applied Biosystems). Gapdh was used as a reference control gene. Primer 
sequences (Table 2.3) were designed using IDT software, unless otherwise 
indicated. All primer pairs were designed to flank exon-exon junctions. Primer 
pairs were validated with a four point standard curve, and only primers offering r2 
values >0.97 were used. 
 
Statistics 
The chi-squared test and studentʼs two-tailed t test were used to ascertain 
differences between groups. A x2 or p-value of less than 0.05 was considered 
significant. 
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Table 2.1. Hdac3Wnt1NCKO mice exhibit perinatal lethality. 
 
Wnt1-Cre; Hdac3f/+ x Hdac3f/+ 
E16.5-E18.5 # Observed Observed #Expected Expected 
Hdac3+/+ 9 0.12 9 0.13 
Hdac3f/+ 17 0.23 19 0.25 
Hdac3f//f 8 0.11 9 0.13 
Wnt1-Cre; Hdac3+/+ 7 0.09 9 0.13 
Wnt1-Cre; Hdac3f/+ 23 0.31 19 0.25 
Wnt1-Cre; Hdac3f/f 11 0.15 9 0.13 
Total 75    
Chi Sq 0.82    
 
P1 # Observed Observed # Expected Expected 
Hdac3+/+ 10 0.14 9 0.13 
Hdac3f/+ 26 0.36 18 0.25 
Hdac3f//f 10 0.14 9 0.13 
Wnt1-Cre; Hdac3+/+ 9 0.12 9 0.13 
Wnt1-Cre; Hdac3f/+ 18 0.25 18 0.25 
Wnt1-Cre; Hdac3f/f 0 0 9 0.13 
Total 73    
Chi Sq 0.03    
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 Table 2.2. Late gestation and perinatal craniofacial abnormalities in 
Hdac3Wnt1NCKO mice. 
 
E16.5-P0 Wnt1-Cre Wnt1-Cre; Hdac3f/f 
Microcephaly 0% (0/14) 100% (19/19) 
Cleft palate 0% (0/14) 100% (19/19) 
Eyelid closure defects 0% (0/14) 100% (19/19) 
Ossification defects of:   
     Calvarium 0% (0/5) 100% (3/3) 
     Mandible 0% (0/5) 100% (3/3) 
     Base of skull 0% (0/5) 100% (3/3) 
     Tympanic rings 0% (0/5) 33% (1/3) 
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Table 2.3. Quantitative RT-PCR primer sequences 
Gene name Protein Sequence (5ʼ – 3ʼ) Product size Genomic size 
     
Alpl 
Alkaline 
phosphatase TGCAAGGACATCGCATATCAG 116 2975 
  TCCAGTTCGTATTCCACATCAG   
     
Bmp2 Bmp2 CGCAGCTTCCATCACGAA 117 6222 
  TGCAGATGTGAGAAACTCGTC  
     
Bmp4 Bmp4 GAGCAGAGCCAGGGAAC 138 1140 
  GAAGAGGAAACGAAAAGCAGAG   
     
Ccnd1 Cyclin D1 GCCCTCCGTATCTTACTTCAAG 145 1538 
  GCGGTCCAGGTAGTTCATG   
     
Ccnd3 Cyclin D3 GCGTGCAAAAGGAGATCAAG 120 1001 
  GATCCAGGTAGTTCATAGCCAG   
     
Ccng1 Cyclin G1 CAGTTCTTTGGCTTTGACACG 147 1597 
  TTCCTCTTCAGTCGCTTTCAC   
     
Cdk2 Cdk2 GCATTCCTCTTCCCCTCATC 128 1251 
  GGACCCCTCTGCATTGATAAG   
     
Cdk4 Cdk4 TACATACGCAACACCCGTGGACAT 155 931 
  AGTCGTCTTCTGGAGGCAATCCAA  
     
Cdkn1a p21 CTTGCACTCTGGTGTCTGAG 145 651 
  GCACTTCAGGGTTTTCTCTTG   
     
Cdkn1b p27 TGGACCAAATGCCTGACTC 144 705 
  GGGAACCGTCTGAAACATTTTC   
     
Cdkn1c p57 CAGGACGAGAATCAAGAGCAG 150 694 
  CGACGCCTTGTTCTCCTG   
     
Cdkn2a p16 Ink4a ATCTGGAGCAGCATGGAGTC 198 5198 
 
(Trivedi et al., 
2008) CGAATCTGCACCGTAGTTGA   
     
Cdkn2c p18 AAACGTCAACGCTCAAAATGG 133 3524 
  GACAGCAAAACCAGTTCCATC   
     
Cdkn2d p19 Ink4d CTTCATCGGGAGCTGGTG 138 1140 
  AGGCATCTTGGACATTGGG   
     
Dmp1 Dmp1 CCCAGTTGCCAGATACCAC 140 4503 
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  CACTATTTGCCTGTCCCTCTG  
     
Gapdh Gapdh CGTCCCGTAGACAAAATGGT 177 2011 
  GAATTTGCCGTGAGTGGAGT   
     
Hdac1 Hdac1 GAGATGACCAAGTACCACAGTG 135 4741 
  AAACAAGCCATCAAACACCG   
     
Hdac2 Hdac2 AGAAGGAGACAGAGGACAAGA 144 3045 
  CGAGGTTCCTAAAGTTGGAGAG   
     
Hdac3 Hdac3 CCATTCTGAGGACTACATCGAC 142 6837 
  TGTGTAACGGGAGCAGAAC   
     
Hdac8 Hdac8 ACCGAATCCAGCAAATCCTC 149 22619 
  CAGTCACAAATTCCACAAACCG   
     
Msx1 Msx1  AAGATGCTCTGGTGAAGGC 132 2296 
  TGGTCTTGTGCTTGCGTAG   
     
Msx2 Msx2 CTCGGTCAAGTCGGAAAATTC 121 3859 
  GTTGGTCTTGTGTTTCCTCAG  
     
Msx3 Msx3 AGTCGCGCACTCTTGTC 141 786 
  TATTGCTTCTGGTGAAACTTGC  
     
Nog Noggin ATCTGGAGCAGCATGGAGTC 116 116 
  CGAATCTGCACCGTAGTTGA   
     
Opg Osteoprogerin AAGAGCAAACCTTCCAGCTGC 104 1762 
  CACGCTGCTTTCACAGAGGTC   
 
(Hesse et al., 
2010)    
Osr1 Osr1 GATGAGCGACCTTACACCTG 124 820 
  ATCCTTTCCCACACTCTTGAC  
     
Osr2 Osr2 TTGCTCATTCACGAGAGGAC 145 1101 
  TCCCACACTCCTGACATTTG   
     
Osx Osterix 
TCTGCTTGAGGAAGAAGCTCACTAT
GGC 345 None 
  AGGCAGTCAGACGAGCTGTGC  
 
(Hesse et al., 
2010)    
Rankl RANK ligand AGGCTCATGGTTGGATGTG 114 5355 
  GAGGACAGAGTGACTTTATGGG  
     
Runx2 Runx2 GCTATTAAAGTGACAGTGGACGG 91 58590 
  GGCGATCAGAGAACAAACTAGG  
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Scx Scleraxis ACACCCAGCCCAAACAG 97 992 
  TCCTTCTAACTTCGAATCGCC  
     
Shh 
Sonic 
hedgehog TCCAAAGCTCACATCCACTG 128 2846 
  CGTAAGTCCTTCACCAGCTTG   
     
Smo Smoothened AGCTGCCACTTCTATGACTTC 126 1096 
  GATCTCACAGTCAGGAATGGG  
     
Spry2 Sprouty 2 AGAGGATTCAAGGGAGAGGG 96 2882 
  ATCAGGTCTTGGCAGTGTG   
     
Tbx1 Tbx1 TGGGACGAGTTCAATCAGC 145 1544 
  TGTCATCTACGGGCACAAAG   
     
Tbx2 Tbx2 CACAAACTGAAGCTGACCAAC 147 1054 
  GAAGACATAGGTGCGGAAGG   
     
Tbx3 Tbx3 AGCCAACGATATCCTGAAACTG 150 1946 
  GTGTCTCGAAAACCCTTTGC   
     
Trp53 p53 AGTTCATTGGGACCATCCTG 149 6524 
  GCTGATATCCGACTGTGACTC   
     
Zfp521 Zfp521 ACAAGATCCATCAGTGCCAG 134 9196 
   CTCTCCGAAATCACACCCTTC   
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Figure 2.1 
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Figure 2.1. Deletion of Hdac3 in neural crest results in cranial hypoplasia at 
E10.5. A. Immunohistochemistry for GFP and Hdac3 in frontal sections of the 
dorsal neural tube (DNT) and dorsal root ganglia (DRG) at E10.5. Wnt1-Cre 
derivatives marked by GFP expression are found in the control (left) and mutant 
DNT and DRG. Mutants exhibit efficient deletion of Hdac3 in premigratory neural 
crest cells in the DNT (arrowhead) and in postmigratory cells in the DRG (arrow), 
while control embryos show Hdac3 expression in both regions. B. Gross 
fluorescent images of E9.5 embryos. Neural crest cells populate the developing 
face and pharyngeal arches in control and mutant embryos. C. 
Immunohistochemistry for GFP and Hdac3 in frontal sections of the rostral 
pharyngeal arches in E10.5 embryos. While the first pharyngeal arch (open 
bracket) is populated by Wnt1-Cre derivates in both control and mutant embryos, 
Hdac3 is efficiently deleted, specifically in neural crest-derived cells (arrowhead). 
D. Quantification of first pharyngeal arch size in three serial sections from control 
and mutant embryos. Error bars indicate standard error of the mean. Asterisk 
denotes p < 0.05. Scale bars: A: 100μm. B: 300μm. C. 400μm. 
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Figure 2.2 
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Figure 2.2. Craniofacial abnormalities in Hdac3Wnt1NCKO mice. A. Gross image 
of a control (left) and mutant P0 pup. Mutants have severe cranial hypoplasia, 
characterized by a shortened snout (bracket) and micrognathia, and are unable 
to feed, as indicated by the lack of a milk spot (arrowhead). Mutants also exhibit 
eyelid dysplasia (arrow). B. Optical projection tomography renderings of P0 
heads. (Left panels) Viewed en face, an area of hemorrhage (black arrowhead) 
and eyelid closure defects (white arrowhead) are visible in the mutant. (Right 
panels) Virtual transverse sections cut through the level of the eyes 
demonstrates a cleft palate (arrow) in the mutant. C. H&E stained coronal 
sections of E17.5 heads. Cleft palate is indicated by the arrow. S: Nasal septum. 
T: Tongue. Scale bars: A: 500μm. B: 2mm. C: 1.4mm. 
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Figure 2.3 
 
	  58	  
Figure 2.3. Deletion of Hdac3 with Pax3Cre recapitulates the craniofacial 
abnormalities observed using Wnt1-Cre. Gross images of E15.5 embryos. 
The mutant exhibits pronounced microcephaly and shortened snout. Scale bar: 
800μm.
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Figure 2.4 
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Figure 2.4. Hdac3Wnt1NCKO embryos exhibit defects in craniofacial bone due 
to dysregulation of important regulators of ossification. A. Alcian blue and 
alizarin red staining of E17.5 heads. Purple staining indicates ossified bone, blue 
staining indicates cartilage. Mutants exhibit incomplete ossification of the 
sphenoid bone (white arrowhead), complete absence of ossification of the frontal 
bone (F) (black arrowhead), and decreased ossification of viscerocranial 
structures such as the tympanic ring (T) (arrow). M: Mandible. B. Goldnerʼs 
trichrome staining of E17.5 heads. Green staining represents bone, red staining 
represents connective tissues. (Inset i) Asterisk (*) indicates cleft palate in the 
mutant. (Inset ii) Open bracket indicates an area of brain herniating through the 
base of the skull in the mutant. (Inset iii): Decreased ossification of the calvarium 
(C) in the mutant. C. Quantitative RT-PCR analysis for regulators of ossification, 
performed on E14.5 microdessected anterior cranial mesenchyme. Gross 
fluorescent images on the left show representations of the area that was 
microdissected to obtain RNA. D. Representative mmunohistochemistry for 
Runx2 and GFP in frontal sections of E14.5 heads. Neural-crest derived cells, 
marked by GFP expression, show decreased expression of Runx2 in regions 
corresponding to the base of the skull and calvarium.  
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Figure 2.5 
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Figure 2.5. The loss of Hdac3 causes hypoplasia of neural crest-derived 
dental mesenchyme. A-F. H & E stained frontal sections of control and mutant 
heads at E17.5. Early stages of tooth morphogenesis, including epithelial 
invagination (A & B), and mesenchymal specification (C & D) occur normally in 
the absence of Hdac3. E&F. However, at E17.5, the dental pulp shows 
decreased bulk in mutants. Ep: Epithelium. M: mesenchyme. Scale bar 200μm. 
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Figure 2.6 
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Figure 2.6. Cell cycle dysregulation and increased apoptosis underlie cleft 
palate in Hdac3Wnt1NCKO mice. A-H. H&E stained frontal sections of control and 
mutant embryos at the level of the palatal shelves. A-D. In control embryos, the 
palatal shelves (P) expand towards the mandible (M) before elevating above the 
tongue (T), meeting in the midline at E14.5 and ossifying by E17.5. E-H. In 
mutant embryos, the palatal shelves are severely hypoplastic at E12.5 and do not 
meet in the midline at E14.5 (*), although the medial aspects of the palatal 
shelves do elevate above the tongue (arrowheads).  I. Images on the left show 
the areas defined as palatal shelves in control and mutant embryos at E12.5. 
Phospho-histone H3 (pH3)- (arrows) and Tunel- (arrowheads) positive nuclei 
were counted relative to total nuclei in serial sections of the pharyngeal arch 
mesenchyme. C. Representative gross fluorescent images showing the area of 
cranial mesenchyme microdissected for expression profiling. D&E. Quantitative 
RT-PCR results for class I Hdacs (D) and cell cycle regulators (E) in E12.5 
cranial mesenchyme. Scale bars: A: 400μm. B: 50μm. C: 150μm.
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Figure 2.7 
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Figure 2.7. Loss of p21 does not rescue craniofacial abnormalities in 
Hdac3Wnt1NCKO mutants. H&E stained frontal sections of E16.5 heads. Neural 
crest deletion of Hdac3 on a p21+/- or p21-/- background results in cleft palate 
(arrow). Scale bar: 400μm. 
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Figure 2.8 
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Figure 2.8. Bmp4 and downstream targets are dysregulated in 
Hdac3Wnt1NCKO cranial mesenchyme. A-B. Quantitative RT-PCR from E12.5 
cranial mesenchyme for (A) transcription factors known to regulate the cell cycle 
in cranial neural crest and palatogenesis and (B) Important signaling molecules 
involved in these processes. C. Quantitative RT-PCR from explanted cranial 
crest cells treated with control, Hdac3 or Bmp4 siRNA. The critical downstream 
Bmp4 target Msx2 is upregulated in the absence of Hdac3, and dysregulation is 
rescued by Bmp4 knockdown. Numbers above brackets denote p values in 
studentʼs two-sided t test. 
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Chapter 3. Hdac3 regulates smooth muscle 
differentiation in neural crest cells and development of 
the cardiac outflow tract 
 
This chapter contains data and text that has been published in Circulation 
Research (Singh et al., 2011). 
 
Summary 
 Chapter 2 discusses craniofacial abnormalities resulting from neural crest 
deletion of Hdac3. Neural crest cells in more caudal regions of the embryo make 
important contributions to the smooth muscle of the cardiac outflow tract (OFT) 
and great vessels, the neurons and support cells of the peripheral nervous 
system, and the chromaffin cells of the adrenal medulla. In this chapter, I 
describe the role of Hdac3 in cardiac OFT development, and contrast it to the 
role of Hdac3 in neural crest-mediated craniofacial and nervous system 
development. 
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Introduction 
Like craniofacial development, mammalian cardiac outflow tract and aortic 
arch morphogenesis is characterized by the tightly coupled development of 
multiple cell types. The complexity of this process is underscored by the 
prevalence of congenital anomalies of great vessel patterning in humans (Jain et 
al., 2010). As discussed in Chapter 1, the heart, OFT and aortic arch are formed 
by several developmentally distinct cell populations, including cardiomyocytes 
(derived from the first and second heart fields), vascular smooth muscle cells 
(derived from the second heart field and neural crest), and endothelial cells 
(Vincent and Buckingham, 2010). These populations of cells interact within the 
maturing pharyngeal arches - a dynamic milieu in which cross-regulation 
between these cell types, as well as the pharyngeal endoderm and ectoderm, 
results in the coordinated development of the OFT, great vessels and 
neighboring structures (Park et al., 2008, Guo et al., 2011). Many of the 
processes that regulate cell fate decisions and patterning during OFT 
development are also active in vascular remodeling in adult disease states in 
humans (Yoshida and Owens, 2005). 
The OFT initially develops as a single vessel, the truncus arteriosus, 
comprised of myocardium and smooth muscle cells emerging from a single, 
unseptated ventricle. Neural crest cells, which make up the bulk of the 
pharyngeal arch mesenchyme, contribute to the smooth muscle of the OFT and 
also condense to form much of the smooth muscle of the aortic arch arteries - a 
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series of paired vessels that connect the developing truncus arteriosus to the 
dorsal aortae (Stoller and Epstein, 2005). The aortic arch arteries are then 
extensively remodeled, eventually giving rise to the mature aortic arch and 
several great vessels. Neural crest cells also contribute to septation and rotation 
of the OFT, with secondary effects on septation of the ventricles. These 
processes are highly dependent on the migration, expansion and differentiation 
of cardiac neural crest in response to cues from neighboring cells (Jain et al., 
2010). 
Murine models of congenital cardiovascular abnormalities have shed new 
light on the interplay between cell populations in the pharyngeal arches, as well 
as on the pathogenesis of human congenital cardiac disease. For instance, 
human mutations in components of the Notch signaling pathway can result in 
Alagille syndrome, a heterogeneous disorder that can include cardiac OFT 
defects. It has been demonstrated in mice that active Notch signaling in both 
neural crest cells and the second heart field is critical for OFT morphogenesis 
(High et al., 2007, High et al., 2009). Notch signaling from endothelial cells to 
neural crest in the pharyngeal mesenchyme via the Notch ligand Jagged1 is 
required to initiate smooth muscle differentiation in the aortic arch arteries; in the 
absence of such signaling, mice develop cardiac abnormalities reminiscent of 
those found in Alagille patients (High et al., 2007). 
Normal development of the OFT relies on intact migration of neural crest 
cells into the pharyngeal arches, survival and proliferation of post-migratory 
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neural crest, differentiation of neural crest cells into smooth muscle, and rotation 
of the developing vasculature, which creates the stereotyped, three-dimensional 
structure of the mature OFT. While Notch signaling drives smooth muscle 
differentiation, other signaling modalities including the WNT, FGF and TGFß 
pathways, as well as activation of the MAPK pathway by integrin signaling 
mediate these additional stages of OFT formation and remodeling (Huh and 
Ornitz, 2010, Guo et al., 2011, Zhang et al., 2010b, Newbern et al., 2008, Vallejo-
Illarramendi et al., 2009).  
In addition to numerous signaling pathways, epigenetic processes and 
chromatin remodeling agents have also been shown to regulate aspects of OFT 
development (Chang and Bruneau, 2011). Human mutations in the chromatin 
remodeling enzyme Chd7 have been associated with neurocristopathy and OFT 
abnormalities (Lalani et al., 2006). In the mouse, Chd7 expression in pharyngeal 
ectoderm regulates the growth of the fourth and sixth pharyngeal arteries and 
formation of the aortic arch (Randall et al., 2009). Chd7 is also required cell-
autonomously by human embryonic stem cell-derived neural crest cells, in order 
to regulate neural crest specification and migration (Bajpai et al., 2010). Chd7 
directly interacts with the PBAF (polybromo- and Brg1-associated factor-
containing complex) chromatin remodeling complex in order to regulate the 
expression of Sox9 and Twist1, both of which play crucial roles in neural crest 
(Bajpai et al., 2010). Brg1-containing nucleosome remodeling complexes also 
regulate the expression of smooth muscle contractile proteins, and smooth 
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muscle-specific deletion of the Brg1 gene in mice results in partially penetrant 
patent ductus arteriosus (Zhang et al., 2011). In the second heart field, Brg1 
expression is required to mediate proliferation and OFT patency (Hang et al., 
2010). 
Histone methylation is an important epigenetic maintainer in many 
developmental processes, including in OFT formation. The polycomb repressor 
complex protein Rae28 regulates cardiac expression of the transcription factor 
Nkx2.5, and Rae28-/- mutant mice demonstrate abnormalities such as double 
outlet right ventricle (DORV) (Shirai et al., 2002). Similarly, endothelial deletion of 
the histone demethylase Jarid2 results in cardiac abnormalities and OFT 
abnormalities including DORV. Loss of Jarid2 results in upregulation of Notch1, 
which drives smooth muscle differentiation in neural crest cells; this provides an 
example of epigenetic control of an important signaling pathway in OFT formation 
(Mysliwiec et al., 2011). 
As discussed in Chapter 1, it is unsurprising that a process as intricate as 
OFT development requires tight regulation of transcription factors and signaling 
molecules by many chromatin remodeling complexes. However, while many such 
complexes have been implicated in OFT development, Class I Hdacs have not 
previously been shown to modulate any aspects of this process. In fact, genetic 
deletion of either Hdac1, Hdac2 or Hdac8 in neural crest does not affect OFT 
development (Haberland et al., 2009a). In this chapter, I use in vivo and ex vivo 
approaches to determine the role of Hdac3 in cardiac outflow tract development 
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and show that there is a specific requirement for Hdac3 in cardiac neural crest 
cells undergoing smooth muscle differentiation. Furthermore, I show evidence of 
a genetic interaction between Hdac3 and the Notch signaling pathway in 
regulating this process. 
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Results 
 
Hdac3 is efficiently deleted in cardiac and trunk neural crest derivatives by 
Wnt1-Cre 
Immunohistochemical analysis reveals that Hdac3 is normally expressed 
in the neural crest-derived pharyngeal arch mesenchyme (Figure 3.1 A), 
conotruncal cushions of the developing outflow tract (Figure 3.1B) and chromaffin 
cells of the adrenal medulla (Figure 3.1 C) embryos at E10.5. In Hdac3Wnt1NCKO 
mutant embryos, Hdac3 protein is absent in each region (Figure 3.1 A-C). Co-
staining for GFP in embryos expressing the Z/EG reporter confirms that Hdac3 
deletion is specific to neural crest derivatives. 
 Quantification of the total number of GFP-positive cells populating the 
caudal pharyngeal arches reveals no significant difference between control and 
mutant embryos at E11.5 (Figure 3.1 D. Therefore the specification and migration 
of cardiac neural crest cells remains intact despite efficient deletion of Hdac3. 
This lies in contrast to the situation in the rostral pharyngeal arches, in which loss 
of Hdac3 leads to pronounced hypoplasia at E10.5 (discussed in Chapter 2). 
 
Loss of Hdac3 in neural crest results in severe cardiovascular and thymus 
abnormalities  
In neurocristopathy in humans, and in multiple mouse models in which 
neural crest developmental processes have been disrupted, craniofacial 
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abnormalities often also portend cardiovascular abnormalities. As neural crest 
cells make important contributions to the development of the cardiac OFT, we 
sought to analyze OFT morphology in Hdac3Wnt1NCKO embryos. Neural crest gives 
rise to the smooth muscle of the aortic arch from its origin to the ductus 
arteriosus and large proportions of the smooth muscle in the great arteries. This 
smooth muscle is critical for vascular integrity during development. In several 
mutant embryos, we observed complete absence of the preductal aortic arch 
(Figure 3.2 A versus 3.2 B), a condition known as interrupted aortic arch (IAA) 
type B in humans. Other mutants demonstrated aortic arch hypoplasia (Figure 
3.2 C). Both IAA type B and aortic arch hypoplasia are rare cardiac abnormalities 
in humans, although both are commonly found in patients with DiGeorge 
syndrome and other neurocristopathies (Morini et al., 2001). 
 In addition to contributing directly to the aortic arch and great arteries, 
neural crest cells are involved in septation and rotation of the OFT, and directly 
give rise to the smooth muscle of the aorticopulmonary septum.  Failure of 
septation can result in persistent truncus arteriosus (PTA), while a combination of 
incomplete septation and deficient outflow tract rotation can result in DORV.  We 
observed examples of PTA and DORV in Hdac3Wnt1NCKO embryos (Figure 3.2 D 
and data not shown). It is thought that neural crest cells in the developing 
aorticopulmonary septum signal to adjacent myocardium during the formation of 
the intraventricular septum. Consistent with the role of neural crest-derived 
smooth muscle in ventricular septation, we have observed severe ventricular 
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septal defects (VSDs) in many Hdac3Wnt1NCKO embryos (Figure 3.2 E). Table 3.1 
summarizes the cardiovascular abnormalities observed in late gestation 
Hdac3Wnt1NCKO embryos. 
In order to provide further support for our findings, we used a distinct 
neural crest Cre driver, Pax3Cre, to delete Hdac3. Hdac3Pax3NCKO also die by P1 
and exhibit a similar array of cardiovascular defects as Hdac3Wnt1NCKO embryos 
(Figure 3.3, Table 3.2, Table 3.3).  These findings support the conclusion that 
Hdac3 is required in cardiac neural crest. 
The thymus is derived primarily from endoderm but develops in close 
association with the pharyngeal arches and neural crest.  The thymic primordia 
migrate caudally through the pharyngeal mesenchyme during midgestation to 
final destinations in the anterior mediastinum. The thymuses of Hdac3Wnt1NCKO 
embryos fail to descend appropriately and are dysplastic (Figure 3.4).   The 
abnormal thymic development in Hdac3Wnt1NCKO embryos is consistent with prior 
studies that have documented the vital role of neural crest during thymus 
development, including in thymic migration, intrathymic smooth muscle formation, 
pericyte formation, and egress of thymocytes (Foster et al., 2008, Foster et al., 
2010, Zachariah and Cyster, 2010). 
 
Peripheral neurogenesis and development of the adrenal medulla occur 
normally in Hdac3Wnt1NCKO embryos 
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 In addition to smooth muscle of the OFT, neural crest cells in the cardiac 
and trunk region form the neurons that populate the dorsal root, sympathetic and 
enteric ganglia, and the chromaffin cells of the adrenal medulla.  In order to 
determine the requirements for Hdac3 in the formation of these derivatives, we 
first analyzed the peripheral nervous system of Hdac3Wnt1NCKO embryos. The 
neurofilament 2H3 is a marker of differentiated neurons. Immunostaining for 2H3 
and GFP reveals that differentiated neurons populate the dorsal root ganglia and 
enteric ganglia of E10.5 Hdac3Wnt1NCKO; Z/EG embryos, and that these cells are 
neural crest-derived (Figure 3.5 A and data not shown). Quantification of 
peripheral neuron staining intensity in the dorsal root ganglia reveals no 
significant difference between mutant and control embryos (Figure 3.5B).  Optical 
projection tomography reconstructions of whole mount 2H3-stained embryos 
revealed normal patterning of the peripheral nervous system, including cranial 
nerves, dorsal root and sympathetic ganglia, in Hdac3Wnt1NCKO embryos 
compared to controls (Figure 3.5 C).  
 The adrenal medullae of E14.5 Hdac3Wnt1NCKO; Z/EG embryos also 
develop normally when compared to control littermates, as determined by 
immunohistochemistry for the neuroendocrine marker tyrosine hydroxylase (TH) 
and for GFP (Figure 3.6). Quantification of TH staining intensity reveals no 
significant abnormalities in chromaffin cell development in the absence of Hdac3 
(Figure 3.6). 
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The aortic arch arteries of E11.5 Hdac3Wnt1NCKO embryos show decreased 
expression of smooth muscle markers 
In midgestation, neural crest cells make up the bulk of the mesenchyme in 
the third, fourth, and sixth pharyngeal arches (Figure 3.1 A,D, Figure 3.7 A,B). A 
subset of these cells directly apposes the endothelium of the developing aortic 
arch arteries (Figure 3.7 B). Between E10.5 and E11.5, these neural crest 
derivatives condense in response to signals from the endothelium and 
differentiate into the smooth muscle of the aortic arch arteries, eventually giving 
rise to a layer of smooth muscle actin (SMA)-positive tissue that is normally 
several cells thick by E11.5 (Figure 3.7 A, C, D) (High et al., 2008).  In mutant 
embryos, as in littermate controls, neural crest cells appropriately populate the 
mesenchyme surrounding the arch arteries (Figure  3.1 D, 3.4 E, F). However, in 
three of four E11.5 mutant embryos, we observed profound deficiencies in 
smooth muscle populating the nascent arch arteries, as assessed by 
immunohistochemistry for SMA and the additional smooth muscle marker SM22α 
(Figure 3.7 E, G, H, Figure 3.8). These defects are particularly pronounced in the 
left fourth and sixth arteries (Figure 3.7 E, I), which give rise to the preductal 
aortic arch and ductus arteriosus, respectively – areas that are affected in late 
gestation Hdac3Wnt1NCKO mutants (Table 3.1).  Of note, parts of the second arch 
arteries that are largely populated by non-neural crest-derived smooth muscle 
cells develop normally in mutants (Figure 3.7 A, E, I). The 75% penetrance of 
gross smooth muscle deficiencies in the caudal arch arteries at E11.5 parallels 
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the penetrance of aortic arch abnormalities observed at E17.5 in Hdac3Wnt1NCKO 
embryos (Table 3.1). Mid-gestational decreases in aortic arch artery smooth 
muscle have previously been shown to portend OFT defects (High et al., 2007), 
and we therefore hypothesized that these smooth muscle deficiencies observed 
at E11.5 account for the late gestational cardiovascular phenotype observed in 
Hdac3Wnt1NCKO embryos. 
 
Hdac3-deficient neural crest cells exhibit a cell autonomous defect in 
smooth muscle differentiation 
In order to determine the mechanism underlying smooth muscle 
abnormalities in E11.5 Hdac3Wnt1NCKO embryos, we first determined rates of 
proliferation and apoptosis in third, fourth and sixth pharyngeal arch 
mesenchyme at E11.5 using phospho-histone H3 and Tunel staining, 
respectively. In contrast to the abnormal cell cycle regulation observed in the first 
pharyngeal arch (Chapter 1), neither proliferation nor apoptosis rates are 
significantly altered in the caudal Hdac3Wnt1NCKO arches when compared to 
littermate controls (Figure 3.7 J). This suggests that neither increases in cell 
death in arch artery smooth muscle, nor decreased smooth muscle proliferation 
contribute to the defects observed. 
Based upon our in vivo observations, we hypothesized that neural crest 
expression of Hdac3 is required for smooth muscle differentiation.  We used an 
ex vivo approach to test this hypothesis. We performed neural tube explant 
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assays using E9.5 Hdac3Wnt1NCKO; Z/EG and Wnt1-Cre; Z/EG control embryos. 
Genetically labeled neural crest cells were allowed to migrate from the dorsal 
neural tube onto a surrounding layer of fibronectin under conditions that allow for 
spontaneous differentiation into smooth muscle. Both control and Hdac3-deficient 
neural crest cells are able to migrate from the dorsal neural tube onto the 
fibronectin layer (Figure 3.9 A, B). However, while control cells assume a large, 
flat conformation after two days in culture, mutant cells maintain a rounder 
phenotype (Figure 3.9 A, B). Co-staining for GFP and SMA revealed that control 
cells are able to efficiently form smooth muscle in culture, while the proportion of 
GFP-positive cells costaining for SMA is significantly lower in mutant explant 
cultures (Figure 3.9 C-G). These results suggest that Hdac3-deficient neural 
crest cells exhibit a primary defect in smooth muscle differentiation, consistent 
with the decreased smooth muscle observed in E11.5 mutant aortic arch arteries. 
 
The Notch ligand Jagged1 is downregulated in Hdac3Wnt1NCKO aortic arch 
arteries 
Notch signaling via the Jagged1 ligand is critical for smooth muscle 
formation in neural crest cells, and loss of Notch signaling in the neural crest 
results in a similar array of OFT defects as observed in this study, with similar 
decreases in aortic arch artery smooth muscle at E11.5 (High et al., 2007). 
Jagged1 is initially expressed in the endothelial cells of the nascent aortic arch 
arteries at E10.5, and in a positive feedback loop, Jagged1 expression is 
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upregulated in surrounding neural crest cells in response to Jagged1-mediated 
Notch activation (High et al., 2008, Feng et al., 2010). OFT development is 
exquisitely dependent on endothelial and neural crest expression of Jagged1; 
indeed, even heterozygous deletion of Jagged1 in neural crest portends OFT 
defects (L. Manderfield, 2011 Circulation, accepted for publication).  
Immunohistochemistry in Hdac3Wnt1NCKO embryos demonstrates that 
Jagged1 expression in the aortic arch arteries is significantly decreased at E11.5 
when compared to Wnt1-Cre littermate controls (Figure 3.10A).  Quantification of 
Jagged1 staining intensity in the region surrounding each aortic arch artery 
indicates that deficient Jagged1 expression is most prominent in the 
mesenchyme surrounding the left fourth aortic arch artery (Figure 3.10B). This 
finding is consistent with our observations of decreased smooth muscle formation 
in this artery, and abnormal development of the left fourth arch artery derivatives 
in late gestation.  
In order to determine the importance of Notch signaling in mediating the 
cardiovascular phenotype of Hdac3Wnt1NCKO embryos, we crossed a conditional, 
constitutively active form of the Notch effector molecule, NICD, into the 
Hdac3Wnt1NCKO background (Stanger et al., 2005). We found that Wnt1-Cre; 
R26NICD/+ embryos die between E12.5-E14.5 of neural tube closure defects (data 
not shown). These embryos also demonstrate gross abnormalities in the 
morphology of the pharyngeal arches, with complete ablation of the left fourth 
and sixth arches at E11.5 (data not shown). These abnormalities preclude direct 
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comparison of the morphology at these regions between control and 
Hdac3Wnt1NCKO embryos in the presence versus the absence of NICD expression. 
However, the area of confluence of the right fourth and sixth arteries remains in 
embryos overexpressing NICD in neural crest. Therefore we have evaluated both 
Jagged1 and SMA staining in this region of the arch arteries. 
Wnt1-Cre; R26NICD/+ embryos demonstrate increased SMA staining as well 
as increased expression of Jagged1 compared to Wnt1-Cre embryos (Figure 
3.11A-F). These observations are consistent with the role of Notch signaling in 
promoting both cell autonomous smooth muscle differentiation as well as 
Jagged1 expression in surrounding cells. In the setting of Hdac3 conditional 
mutants, we have observed increased SMA staining in Wnt1-Cre; Hdac3f/f; 
R26NICD/+ embryos compared to Wnt1-Cre; Hdac3f/f litermates; this SMA staining 
is comparable to that observed in Wnt1-Cre; R26NICD/+ embryos (Figure 3.11G-L. 
However, we do not observe ectopic Jagged1 expression in Wnt1-Cre; Hdac3f/f; 
R26NICD/+ embryos, as in Wnt1-Cre; R26NICD/+ arches (Figure 3.11G-L).  
Constitutive Notch activation in neural crest therefore results in cell 
autonomous rescue of smooth muscle expression, without ectopic expression of 
Jagged1. These observations are consistent with a model in which Hdac3 is 
important in mediating Notch-mediated Jagged1 expression.  
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Discussion 
 
In this study, we have elucidated a specific role for Hdac3 in smooth 
muscle differentiation of cardiac neural crest cells during OFT and aortic arch 
artery morphogenesis. The specificity of this role is underscored by the lack of 
peripheral nervous system or adrenal abnormalities in Hdac3Wnt1NCKO mutants. 
The smooth muscle deficiencies observed in Hdac3Wnt1NCKO embryos lead to OFT 
and aortic arch artery abnormalities, such as DORV, PTA and type B IAA – 
abnormalities that are attributable to a failure of cardiac neural crest-derived 
structures to form properly (Stoller and Epstein, 2005). It is interesting to note 
that while these abnormalities are commonly found in human patients with 
neurocristopathy, additional OFT malformations often found in such patients, 
including retroesophageal right subclavian artery and vascular rings, were not 
observed in this study; this is likely because these latter two lesions are generally 
associated with abnormal persistence of structures which normally regress during 
development, rather than with the failure of such structures to form appropriately 
(Stoller and Epstein, 2005). 
In the pharyngeal arches, populations of neural crest cells, pharyngeal 
endoderm, epithelial cells and cardiomyocytes exist in close association with one 
another, and exert important regulatory roles mediating cell-cell communication. 
The signals between these cells exist in a delicate balance, and are instrumental 
for coordinating their migration, proliferation and differentiation. Cardiac OFT 
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malformations have been described as a common endpoint for disruptions to 
these processes in the pharyngeal arches; indeed, numerous mouse models in 
which crosstalk between progenitor cell populations is disrupted result in a wide 
array of OFT defects (Jain et al., 2010, Huh and Ornitz, 2010, Guo et al., 2011, 
Zhang et al., 2010b, Newbern et al., 2008, Vallejo-Illarramendi et al., 2009, High 
et al., 2008). Notch signaling via the Jagged1 ligand has previously been shown 
to initiate a cascade of smooth muscle differentiation in the aortic arch arteries, 
as well as to upregulate the expression of Jagged1 itself, in a positive feedback 
loop (High et al., 2008, Feng et al., 2010). The decreased expression of Jagged1 
in the aortic arch arteries of Hdac3Wnt1NCKO embryos suggests that Hdac3 may be 
required for Notch-mediated upregulation of Jagged1 and subsequent 
propagation of smooth muscle differentiation in the aortic arch arteries. Future 
work will elucidate the direct targets of Hdac3 that are responsible for its 
regulation of smooth muscle differentiation and Jagged1 be it through direct 
deacetylation of transcription factor targets, or via epigenetic silencing of target 
loci.  
In addition to its relevance to congenital heart disease, smooth muscle 
formation is clinically important in the setting of coronary arterial stent restenosis, 
where proliferation of smooth muscle cells results in neointimal hyperplasia. 
Agents such as sirolimus, and rapamycin have been shown to be clinically useful 
in preventing restenosis at least in part by shifting the balance of smooth muscle 
cells from a proliferating, less differentiated phenotype towards a more quiescent 
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and contractile cell type (Martin et al., 2004, Hegner et al., 2009). Many of the 
pathways involved in smooth muscle formation in embryogenesis are thought to 
be similarly involved in smooth muscle differentiation and vascular remodeling in 
the adult (Owens et al., 2004). While we have demonstrated a requirement for 
Hdac3 in smooth muscle differentiation during embryonic cardiac development, 
additional work is needed to determine whether Hdac3 plays an analogous role in 
smooth muscle formation and phenotypic modulation in the adult vasculature. 
Hdac inhibitors are widely used therapeutic agents and have previously been 
proposed as useful agents in the treatment of heart failure (Trivedi et al., 2007). 
Given a potential role of Hdac3 in modulation of vascular smooth muscle 
behavior, vascular effects of Hdac inhibitors in various patient populations, 
including those with coronary disease and vascular stents, will be interesting 
topics for future study. 
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Materials and Methods 
 
Mice 
To evaluate the role of Notch signaling in mediating the cardiovascular 
phenotype in Hdac3Wnt1NCKO mice, Wnt1-Cre; Hdac3f/+ mice were crossed to 
Hdac3f/+; R26NICD/+ mice (Stanger et al., 2005). Additional crosses and 
techniques are described in Chapter 2. All animal protocols were approved by the 
University of Pennsylvania Institutional Animal Care and Use Committee. 
 
Micrographs, Histology and immunohistochemistry 
These techniques are described in Chapter 2. For gross pictures of OFTs, 
image brightness and contrast were adjusted in Adobe Photoshop to enhance 
OFT detail. OFT morphological diagrams were obtained by tracing and false-
coloring H&E images in Adobe Illustrator 
Primary antibodies used for immunohistochemistry were anti-GFP goat 
polyclonal (Abcam AB6673, 1:100), anti-GFP rabbit polyclonal (Invitrogen A-
11122, 1:200), rabbit polyclonal anti-HDAC3 (Santa Cruz sc-11417x, 1:10), 
mouse monoclonal anti-SMA (Sigma A2547, 1:200), mouse polyclonal Anti-2H3 
(Iowa Hybridoma Bank, 1:25), rabbit polyclonal anti-tyrosine hydroxylase 
(Chimicon AB152, 1:500), rabbit polyclonal anti-Jagged-1 (Santa Cruz SC-8303, 
1:10). 
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 All control versus mutant histological and immunohistochemical images 
were taken at the same exposure and contrast settings, using NIS Elements 
software. ImageJ software was used to merge images and for quantification of 
neurofilament and tyrosine hydroxylase staining intensity. In some cases, ImageJ 
was used to decrease image brightness, and this was performed identically in 
control and mutant images. Quantification of dorsal root ganglion and adrenal 
medulla size was performed using multiple serial sections from multiple control 
and mutant samples that were matched for anatomical landmarks.  
Cell number, proliferation and apoptosis in pharyngeal arches III-VI were 
quantified by manually counting nuclei, pHistone H3-, or Tunel-positive cells, 
respectively, in adjacent sections of the anatomically-defined pharyngeal arch 
region in a blinded manner. For quantification of SMA and Jagged1 staining 
intensity, serial sections from three severely affected E11.5 Wnt1-Cre; Hdac3f/f 
embryos were compared to littermate Wnt1-Cre and Wnt1-Cre; Hdac3f/+ control 
embryos.  Quantification was performed using ImageJ in a blinded manner. 
 
Whole mount immunostaining and optical projection tomography. 
E10.5 embryos were fixed in 4% paraformaldehyde overnight. Embryos were 
bleached for 30 minutes in 5% H2O2 in PBST, digested in 10µg/mL proteinase K 
in PBST for 5 minutes and immunostained with mouse polyclonal Anti-2H3 (Iowa 
Hybridoma Bank, 1:100). An HRP Conjugated secondary antibody and DAB 
substrate kit (Vector Laboratories) were used to visualize peripheral nerves.  
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For OPT scanning, immunostained embryos were dehydrated into 100% 
methanol, embedded in 1% low-melt agarose, cleared overnight in 1:2 (v/v) 
benzyl alcohol and benzyl benzoate, and scanned using the Bioptonics OPT 
scanner (3001M) (Sharpe et al., 2002). Image stacks were reconstructed using 
OsiriX software. Image contrast was optimized to reveal peripheral nerve 
patterning. 
 
Neural Tube Explant Assays 
Mutant embryos were obtained from crosses in which Wnt1-Cre; Hdac3f/+; 
Z/EG males were crossed to Hdac3f/f females, and age-matched control embryos 
were generated from Wnt1-Cre; Z/EG males crossed to WT females. Control and 
mutant embryos were dissected in parallel in a blinded manner. E9.5 embryos 
were dissected in sterile Hankʼs balanced salt solution (HBSS) supplemented 
with 1% penicillin/streptomycin.  The neural tube from the otic placode to first 
dorsal root ganglion was dissected and incubated in 0.75mg/mL type I 
collagenase (Worthington biochemical) in HBSS for 20 minutes at 37°C. Using 
tungsten needles, the neural tube was then microdissected from the surrounding 
mesenchyme, split in half longitudinally, and plated on glass chamber slides pre-
coated with 200µg/mL fibronectin (Roche). Explants were incubated for 48 hours 
at 37°C and 5% CO2 in DMEM supplemented with 2% horse serum and 1% 
penicillin/streptomycin.  Following fixation and immunostaining, each GFP+ cell 
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that had delaminated from the neural tube was scored as SMA-positive or SMA-
negative. 
 
Statistics 
The chi-square test and studentʼs 2-tailed t test were used to ascertain 
differences between groups. A x2 or p-value of less than 0.05 was considered 
significant. 
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Table 3.1. Late gestation cardiovascular and thymic abnormalities in 
Hdac3Wnt1NCKO embryos. 
 
E16.5-18.5 Wnt1-Cre Wnt1-Cre; Hdac3f/f 
 
IAA type B 0% (0/6) 32% (6/19) 
Aortic arch hypoplasia 0% (0/6) 16% (3/19) 
PTA 0% (0/6) 5% (1/19) 
DORV 0% (0/6) 26% (5/19) 
VSD 0% (0/6) 69% (11/16) 
   
Thymic Dysplasia 0% (0/6) 100% (19/19) 
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Table 3.2. Hdac3Pax3NCKO die by P1. 
 
 
Pax3Cre/+; Hdac3f/+ x Hdac3f/+ 
P1 # Observed Observed # Expected Expected 
Hdac3+/+ 6 0.08 9 0.13 
Hdac3f/+ 25 0.35 17 0.25 
Hdac3f//f 13 0.18 9 0.13 
Pax3Cre/+;; Hdac3+/+ 9 0.13 9 0.13 
Pax3Cre/+;; Hdac3f/+ 18 0.25 17 0.25 
Pax3Cre/+;; Hdac3f/f 0 0 9 0.13 
Total 71    
Chi Sq 0.01    
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Table 3.3. Late gestation cardiovascular and thymic abnormalities 
observed in Hdac3Pax3NCKO embryos recapitulate those observed using 
Wnt1-Cre. 
 
E16.5-18.5 Pax3Cre; Hdac3f/+ Pax3Cre; Hdac3f/f 
 
IAA type B 0% (0/6) 50% (6/12) 
Aortic arch hypoplasia 0% (0/6) 0% (0/12) 
PTA 0% (0/6) 17% (1/12) 
DORV 0% (0/6) 17% (2/12) 
Dorsal edema 0% (0/6) 100% (12/12) 
   
Thymic Dysplasia 0% (0/6) 100% (12/12) 
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Figure 3.1 
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Figure 3.1. Wnt1-Cre efficiently deletes Hdac3 in the pharyngeal arch 
mesenchyme,  conotruncal cushions and adrenal medulla. A-C, 
Immunohistochemistry for GFP and Hdac3 A, Frontal sections of the pharyngeal 
arches at E10.5. Neural crest derivatives expressing GFP populate the 
pharyngeal arches of control (left) and mutant embryos. In control embryos, 
Hdac3 is expressed throughout the pharyngeal arch region. Mutant embryos 
show deletion of Hdac3 in the neural crest-derived pharyngeal mesenchyme 
(arrows), with retention of Hdac3 expression in ectoderm and pharyngeal 
endoderm (arrowheads). Roman numerals denote pharyngeal arch number. B. 
Frontal sections of the conotruncal cushions at E10.5. Neural crest derivatives, 
marked by GFP expression, are found in the conotruncal cushions in both control 
(left) and mutant embryos. Mutant embryos demonstrate loss of Hdac3 
expression in GFP-positive neural crest derivatives (arrowheads). C. Sagital 
sections of E14.5 adrenal glands. The adrenal medulla of control (left) and 
mutant embryos is populated by neural crest derivatives. Mutants demonstrate 
loss of Hdac3 expression specifically in GFP-positive cells (arrows), which 
represent chromaffin cells. Scale bars: D. Quantification of cells in the pharyngeal 
mesenchyme of aortic arches III-VI from serial sections of E11.5 control and 
mutant embryos. A & B. 100μm, C. 400μm 
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Figure 3.2 
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Figure 3.2. Late gestation Hdac3Wnt1NCKO embryos exhibit severe 
cardiovascular abnormalities. A-C. Gross images and drawings of E17.5 aortic 
arches. A. A control embryo, showing normal patterning of the great vessels in 
late gestation. B. A mutant embryo demonstrating a complete discontinuity of the 
aortic arch (open bracket), similar to interrupted aortic arch type B in humans. C. 
A mutant embryo showing hypoplasia of the aortic arch (arrowhead). A, aorta; P, 
pulmonary trunk; RS, right subclavian artery; RC, right common carotid artery; 
LC, left common carotid artery; LS, left subclavian artery. D. Sequential H&E-
stained slides from the same control (top) and mutant hearts. In the control heart, 
the pulmonary trunk arises from the right ventricle (RV) while the aorta arises 
from the left ventricle (LV). In this mutant, both the pulmonary trunk and the aorta 
(arrow) arise from the right ventricle, indicating a double outlet right ventricle. E. 
A control embryo (top) with an intact ventricular septum and a littermate mutant 
with a large ventricular septal defect (*). The ventricular septal defect is the only 
cardiac abnormality in this mutant. Scale bars: A-C. 1mm, D,E. 300μm. 
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Figure 3.3 
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Figure 3.3. Cardiac abnormalities in late gestation Hdac3Pax3NCKO embryos. 
Sequential H&E- stained slides from the same control (top) and mutant hearts. In 
control hearts, the pulmonary trunk arises from the right ventricle (RV) while the 
aorta arises from the left ventricle (LV). In this mutant, both the pulmonary trunk 
and the aorta (arrow) arise from the right ventricle, indicating a double outlet right 
ventricle. Scale bar: 300μm.  
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Figure 3.4 
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Figure 3.4. Hdac3Wnt1NCKO embryos exhibit thymic abnormalities. Gross 
pictures of the mediastinum of control and mutant embryos at E16.5. By E16.5 
the thymus (outlined in broken white line) normally sits ventral to the atria, as 
shown in the control (left). The mutant thymus is irregularly-shaped and has 
failed to descend correctly. Scale bar: 1mm.  
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Figure 3.5 
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Figure 3.5. Peripheral neurogenesis occurs normally in the absence of 
neural crest expression of Hdac3. A. Immunohistochemistry for GFP and 
neurofilament (2H3), a marker of differentiated neurons, in frontal sections of the 
dorsal neural tube (DNT) and dorsal root ganglia (DRG). Both control and Mutant 
DRG feature differentiated, 2H3-positive neurons at E10.5 (arrowheads). B. Total 
neuronal area was calculated from anatomically matched sections from control 
and mutant embryos. Error bars represent SEM. N.S., not significantly different. 
C. Optical projection tomography renderings of whole mount 2H3-stained E10.5 
embryos. Cranial nerves V, VII-XII (labeled) and DRG are present and patterned 
appropriately in mutant embryos. Scale bars: A. 100μm, B. 400μm. 
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Figure 3.6 
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Figure 3.6. Chromaffin cells of the adrenal medulla develop normally in the 
absence of Hdac3. Immunohistochemistry for GFP and tyrosine hydroxylase 
(TH), a marker of neuroendocrine cells, in sagital sections of adrenal glands. 
Control (left) and mutant adrenal medulla are populated by TH-positive, neural 
crest-derived chromaffin cells. Quantification of TH- positive area was obtained 
from two serial sections of five control and five mutant adrenal glands. Scale bar: 
100μm.
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Figure 3.7 
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Figure 3.7. Hdac3Wnt1NCKO embryos display deficiencies in aortic arch artery 
smooth muscle at E11.5. A-H. Immunohistochemistry for GFP and α-smooth 
muscle actin (SMA) in frontal sections of E11.5 pharyngeal arches. A. 
Representative image of a control pharyngeal arch at low magnification, showing 
robust layers of smooth muscle surrounding aortic arch arteries II, III, IV and VI 
(labeled), bilaterally. Note that the bulk of pharyngeal mesenchyme is comprised 
of GFP-positive neural crest derivatives. B-D. High magnification images of the 
left fourth arch artery in the control embryo. B. Neural crest cells populate the 
region directly surrounding the artery. C,D. A layer of neural crest-derived, SMA-
positive smooth muscle surrounds the control artery. E. Low magnification image 
of a mutant pharyngeal arch, showing neural crest derivatives populating the 
mesenchyme. Note the decreased smooth muscle in the regions surrounding the 
third, fourth and sixth arteries, particularly on the left side, while a thick layer of 
non-neural crest-derived smooth muscle surrounds the second arteries, as in the 
control F-H. High magnification images of the mutant left fourth artery. F. Neural 
crest cells appropriately populate the region surrounding the artery. G,H. In 
affected mutants, few neural crest-derived cells surrounding the fourth arch artery 
are SMA-positive smooth muscle cells. Three of four mutant and zero of four 
control embryos analyzed at this time point showed a similar pattern of staining. 
Roman numerals denote aortic arch artery number. I. Quantification of SMA 
staining intensity of each aortic arch artery, from serial sections in control and 
mutant embryos. Asterisks denote p < 0.05. J. Quantification of phospho-histone 
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H3 (pH3)- and Tunel-positive in serial sections of the pharyngeal arch 
mesenchyme. Scale bars: 100μm. 
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Figure 3.8 
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Figure 3.8. Hdac3Wnt1NCKO pharyngeal arches display decreased expression 
of the smooth muscle marker Sm22α in the aortic arch arteries at E11.5. 
Immunohistochemistry for Sm22α and Hdac3 in frontal sections from E11.5 
pharyngeal arches. Hdac3 is deleted in the neural crest-derived cells surrounding 
the nascent pharyngeal arches in mutant embryos. These embryos are also 
characterized by decreased expression of Sm22α. High magnification images 
show the left sixth artery. Scale bars: 100μm. 
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Figure 3.9 
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Figure 3.9. Hdac3-deficient neural crest cells demonstrate a cell 
autonomous defect in smooth muscle differentiation. A-F. 
Immunocytochemistry for GFP and α-smooth muscle actin (SMA) in neural tube 
explant cultures. A,B. Representative images of control and mutant neural crest 
cells following two days of migration and growth. Note that mutant neural crest 
cells (B) are small and blastic compared to control cells (A). C-F. Significant 
numbers of control cells stain positive for SMA (C,E) while mutant cells are rarely 
SMA-positive (D,F). G. Each GFP-positive cell derived from four control and four 
mutant embryos was scored as SMA-positive or -negative. Scale bar: 100μm. 
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Figure 3.10 
 
 
	  114	  
Figure 3.10. Expression of the Notch ligand Jagged1, a critical regulator of 
smooth muscle differentiation in the aortic arch arteries, is dysregulated in 
Hdac3Wnt1NCKO arches at E11.5. A. Representative immunohistochemistry for 
SMA and Jagged1 from frontal sections of mutant versus control left fourth and 
sixth arch arteries. B. Quantification of Jagged1 staining intensity in serial 
sections from three severely affected mutants relative to controls. Scale bar: 
100μm. 
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Figure 3.11 
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Figure 3.11. Overexpression of the notch intracellular domain partially 
restores smooth muscle in developing aortic arch arteries. A-L. 
Immunohistochemistry for SMA and Jagged1 in frontal sections from E11.5 
embryos at the confluence of the right fourth and sixth aortic arch arteries. A-C. A 
Control embryo showing the normal morphology at E11.5. Note the 
discontinuities in SMA staining in the region surroundind the fourth and sixth arch 
ateries. D. SMA staining in the setting of Notch overexpression in neural crest. 
Note the robust layer of smooth muscle surrounding the confluence, which is 
more robust than in the littermate control embryo. E-F. With overexpression of 
Notch, areas of ectopic Jagged1 expression are observed (open bracket), 
consistent with the existence of a Notch-Jagged1 positive feedback loop. G-I. In 
a litermate Hdac3Wnt1NCKO mutant, there are large areas of discontinuous SMA 
staining and decreased expression of Jagged1. J. Overexpression of NICD in the 
Hdac3Wnt1NCKO background in a littermate embryo results in robust SMA staining 
in the confluence. K-L. Ectopic Jagged1 expression is not observed in this 
embryo. Roman numerals delineate arch arteries. Scale bar: 50μm. 
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Chapter 4. Conclusions and future directions 
 
Summary 
 The development of complex organisms is driven by the genesis of 
multiple distinct cell types from common progenitor cells. Given that each 
differentiated cell possesses the same genome as its progenitor cell precursor 
but exhibits a unique transcriptional and phenotypic profile, development is an 
inherently epigenetic process. The epigenetic regulation of progenitor cell biology 
has become an area of increasing investigation. Chromatin remodeling enzymes, 
including class I Hdacs, have proven to be important regulators of many aspects 
of progenitor cell behavior, including their differentiation. Furthermore, class I 
Hdacs have now been implicated in the converse process – the de-differentiation 
of committed cells into induced pluripotent progenitor cells (Anokye-Danso et al., 
2011). 
In this dissertation, I have used mouse genetics to explore the role of the 
chromatin remodeling enzyme Hdac3 in regulating distinct aspects of neural crest 
progenitor cell biology. In Chapter 2, I discuss the role of Hdac3 in neural crest-
mediated craniofacial development. I have suggested that Hdac3 is required for 
the repression of the signaling molecule Bmp4 in neural crest cells, and that in 
the absence of Hdac3, excessive Bmp4 signaling results in aberrant cell cycle 
regulation and craniofacial abnormalities (Figure 4.1). Additionally, Hdac3 plays 
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an important role in osteogenesis, in part, through regulation of the important 
regulatory factor Runx2. In Chapter 3, I discuss the role of Hdac3 in cardiac 
outflow tract formation. Hdac3 is required for neural crest-mediated smooth 
muscle differentiation via the Notch signaling pathway (Figure 4.2). However, 
with regard to the role of Hdac3 in each of these distinct aspects of neural crest 
development, interesting questions, further discussed below, remain. 
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Discussion and Future Directions 
 
Is there a single, parsimonious explanation for the cardiac and craniofacial 
abnormalities in Hdac3Wnt1NCKO embryos? 
 Craniofacial and cardiac abnormalities often segregate together, both in 
human congenital abnormalities, and in mouse models in which various aspects 
of neural crest development have been genetically perturbed (Benish, 1975, Huh 
and Ornitz, 2010, Guo et al., 2011, Zhang et al., 2010b, Newbern et al., 2008, 
Vallejo-Illarramendi et al., 2009). Deletion of Hdac3 in neural crest yields an array 
of abnormalities reminiscent of those found both in patients with DiGeorge 
syndrome and in numerous murine models of neural crest abnormalities in which 
a single process has been disrupted. Therefore we have asked whether there 
exists a single, parsimonious explanation for the spectrum of abnormalities 
described in Hdac3Wnt1NCKO mice. The mechanistic analysis of the craniofacial 
and cardiovascular phenotypes, presented in Chapters 2 and 3, however, 
suggests that dysregulation of a single gene or pathway is unlikely to account for 
the phenotype of Hdac3Wnt1NCKO mice. 
 In cardiac outflow tract (OFT) development, we found that loss of Hdac3 
results in decreased smooth muscle differentiation. We have implicated 
decreased Notch signaling via the Jagged1 ligand as one mechanism through 
which this smooth muscle differentiation defect occurs. Notch signaling is not 
involved in most aspects of craniofacial morphogenesis, including palatogenesis, 
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suggesting that the majority of craniofacial abnormalities in Hdac3Wnt1NCKO pups 
do not occur due to Notch inhibition. However, Notch inhibition in neural crest – 
either by genetic deletion of Jagged1 or by expression of a dominant negative 
form of the transcription factor MAML - results in ossification abnormalities of the 
frontal bone (Frances High, unpublished). These abnormalities are similar to 
frontal bone abnormalities observed in Hdac3Wnt1NCKO pups. Therefore the 
Hdac3-mediated regulation of Jagged1 expression may, in part, contribute to the 
ossification defects observed in Hdac3Wnt1NCKO embryos. However, Notch 
inhibition is unlikely to contribute to additional craniofacial abnormalities. 
 In Chapter 1, I describe that the survival of cranial neural crest derivatives 
is significantly decreased in the absence of Hdac3, while in Chapter 2 I show that 
proliferation and apoptosis in cardiac neural crest are unaffected. The decrease 
in survival in craniofacial crest – mediated by dysregulation of a Bmp4-Msx2 
pathway, is consistent with many of the craniofacial abnormalities identified in 
Hdac3Wnt1NCKO mutants. In OFT development, Bmp4 and Msx genes are actually 
required for smooth muscle differentiation, cardiac crest survival and OFT 
remodeling, suggesting that their upregulation would not portend the OFT defects 
observed in Hdac3Wnt1NCKO embryos (Stottmann et al., 2004, Chen et al., 2007, 
Nie et al., 2011, Zhang et al., 2010a). Indeed, ectopic activation of Bmp or Msx 
activity in vivo in the neural crest does not produce OFT defects (Winograd et al., 
1997, He et al., 2010).	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   Our results therefore suggest that Hdac3 mediates distinct processes in 
craniofacial and cardiovascular development, and that dysregulation of a single 
gene or pathway is unlikely to account for the full spectrum of abnormalities 
described in this dissertation. 
  
What is the nature of Hdac3-mediated repression of Bmp4? 
 Bmp signaling – particularly from ectodermal structures to neural crest 
cells - is important in multiple stages of craniofacial development (He et al., 2010, 
Zhang et al., 2000, Nie et al., 2006, Zhang et al., 2002). Bmp4 is expressed in 
the dorsal neural tube prior to neural crest cell delamination, and in the chick this 
signal has been shown to mediate apoptosis in a subset of neural crest cells 
(Graham et al., 1994). Later, as neural crest cells populate the face, Bmp signals 
from the epithelium regulate the survival and expansion of those cells, particularly 
in palatogenesis and tooth formation (Zhang et al., 2000, Zhang et al., 2002). We 
have proposed a model in which Hdac3 restricts Bmp4 transcription in cranial 
neural crest, in order to regulate the growth and survival of these cells. We have 
demonstrated that loss of Hdac3 leads to upregulation of Bmp4, upregulation of 
targets of Bmp4 signaling, and craniofacial abnormalities. However, some 
craniofacial abnormalities described in this study, including ossification defects, 
have not previously been associated with increased Bmp4 activity. While 
ectodermal expression of Bmp4 is required for craniofacial morphogenesis, 
studies using a floxed allele of Bmp4 have revealed that deletion of Bmp4 in 
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neural crest tissue itself does not affect craniofacial morphogenesis (Neves et al., 
2011). A useful experiment for discerning which abnormalities in Hdac3Wnt1NCKO 
embryos are mediated by cell autonomous upregulation of Bmp4 in neural crest 
cells would involve rescuing the defects on a Bmp4flox/flox background. Our model 
would predict that craniofacial hypoplasia, cleft palate and dental abnormalities 
would be rescued by deletion of Bmp4, while ossification abnormalities would 
persist. 
The transcriptional regulation of Bmp4 expression is a complex area of 
investigation. LacZ reporters spanning a 180kb region flanking the Bmp4 coding 
sequence recapitulate only a small fraction of the normal Bmp4 expression 
pattern during embryogenesis (Chandler et al., 2009). The Bmp4 gene exists in a 
highly conserved gene desert of over 1MB (Pregizer and Mortlock, 2009). This 
region is believed to contain multiple enhancer elements that drive Bmp4 
expression, although the locations of these enhancers remain largely unknown 
(Pregizer and Mortlock, 2009). In light of the role of Hdac3 as a transcriptional 
repressor, we have hypothesized that Hdac3 directly represses Bmp4 expression 
in neural crest by deacetylating histones at one or more of these Bmp4 enhancer 
element. While relevant enhancers driving neural crest expression of Bmp4 
remain undescribed, ChIP-Seq for Hdac3 in cranial crest would identify potential 
sites of Hdac3 regulation in neural crest. Putative sites could then be cloned 
upstream of reporters in order to determine whether they direct neural crest 
transcription in the presence or absence of Hdac3. This approach could address 
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the question of whether Hdac3-mediated inhibition of Bmp4 transcription is direct 
or indirect, and could also contribute to our understanding of how Bmp4 
transcription is regulated by distant-acting enhancers. 
 
 
What is the nature of the genetic interaction between Hdac3 and Notch 
signaling in OFT development? 
 In Chapter 3 I describe a genetic interaction between Hdac3 and the 
Notch-Jagged1 positive feedback loop in smooth muscle differentiation. Notch 
signaling activates smooth muscle differentiation in a cell autonomous manner 
(High et al., 2007). As well, smooth muscle differentiation in the aortic arch 
arteries relies on this feedback loop to propagate the differentiation signal from 
the endothelium into the surrounding neural crest-derived mesenchyme (High et 
al., 2008, Feng et al., 2010). The evidence presented in Chapter 3 suggests that 
Hdac3 is required for Notch-mediated upregulation of Jagged1 expression, but 
not for cell autonomous NICD-mediated smooth muscle differentiation. However 
the nature of this requirement is unclear. 
 A plausible model to explain the interaction between Hdac3 and Notch 
signaling is one in which Hdac3 is responsible for repressing the expression of 
an inhibitor of the positive feedback loop via its role as a chromatin remodeling 
enzyme. Thus, in the absence of Hdac3, the positive feedback loop would be 
broken, with resulting deficiencies in smooth muscle differentiation. Smooth 
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muscle differentiation involves complex interactions between multiple signaling 
pathways, and it has been hypothesized that there is extensive positive and 
negative cross-regulation between these pathways (Owens et al., 2004). 
Therefore a screen among pathway components of these signaling pathways as 
well as additional known Notch inhibitors could prove fruitful for identifying 
potential inhibitors of Notch-mediated Jagged1 expression that are derepressed 
in the absence of Hdac3. 
  
Is Hdac3 required for differentiation and/or survival of additional smooth 
muscle populations? 
 As discussed in Chapter 3, determining the mechanism of smooth muscle 
differentiation is relevant not only to developmental and regenerative biology, but 
to the study of adult disease processes (Yoshida and Owens, 2005). In Chapter 
3 I discuss a novel and important pathway that regulates neural crest-derived 
smooth muscle differentiation, and we are interested in the applicability of this 
mechanism to additional developmental processes. One useful strategy for 
determining whether Hdac3 is required for differentiation of other smooth muscle 
populations, or for the survival of differentiated smooth muscle cells, is to cross 
the Hdac3f allele to existing Cre lines and analyze smooth muscle derivatives in 
late gestation. 
 The smooth muscle of the descending aorta and much of the body 
vasculature is derived from the lateral plate mesoderm. Mice in which Hdac3 is 
	  125	  
deleted with the mesoderm-specific Mesp1-Cre die at E9.5, and preliminary 
analysis reveals evidence of circulatory collapse consistent with a failure of the 
vasculature to be formed correctly. However, preliminary analysis of Sema3D-
Cre; Hdac3f/f embryos, in which Hdac3 is deleted in precursors of the smooth 
muscle of the coronary vasculature, suggests that these mice develop normally. 
Detailed analysis of these mice will reveal whether the requirement for Hdac3 in 
smooth muscle differentiation applies only to specific smooth muscle lineages. 
Based on the normal rates of proliferation and apoptosis observed in 
Hdac3Wnt1NCKO E11.5 aortic arch arteries, we hypothesized that deletion of Hdac3 
does not affect the survival of differentiated smooth muscle cells. Sm22α-Cre is 
expressed in committed, early stage smooth muscle cells. Preliminary analysis of 
Sm22α-Cre; Hdac3f/f embryos suggests that deletion of Hdac3 using Sm22α-Cre 
does not affect patterning of the OFT and aortic arch, supporting our hypothesis 
that Hdac3 is required for smooth muscle differentiation, but ultimately not for the 
survival of differentiated cells. 
 
How is Hdac3 targeted to genomic loci in different neural crest lineages? 
 As discussed in Chapter 2, the Hdac3-NCoR/Smrt corepressor complex 
does not possess intrinsic DNA binding ability. Rather, it is targeted to specific 
genomic loci by transcription factor and nuclear receptor binding partners. We 
have hypothesized that the preponderance of abnormalities resulting from the 
loss of Hdac3 in neural crest occurs due to the loss of Hdac3-mediated 
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transcriptional repression at specific loci. Therefore an exciting area of research 
will involve determining the binding partners of the Hdac3 coreprssor complex 
that lead to its genomic localization in neural crest.  
Interesting candidate transcription factors include Hox family members, 
including Msx proteins. Hox proteins are differentially expressed along the rostro-
caudal axis of neural crest and bind DNA in a sequence-specific manner 
(Marshall et al., 1992). In many developmental contexts, they have been shown 
to act both as transcriptional activators and transcriptional repressors - the latter 
activity occurring through direct interaction with chromatin remodeling complexes, 
incuding Hdac3-NCoR/SMRT (Saleh et al., 2000). Interestingly, abnormalities in 
Hox gene expression can cause a number of the defects observed with Hdac3 
deletion	  (Makki and Capecchi, 2011).  
Hdac3 ChIP-Seq studies described above would be useful for determining 
whether Hox proteins or additional classes of transcription factors dictate the 
genomic localization of Hdac3 in neural crest. Bioinformatic analysis of neural 
crest Hdac3 enrichment sites determined by ChIP-Seq could reveal putative 
binding sites for known transcription factors, including Hox proteins. Predicted 
interacting partners could then be validated by Co-IP and sequential ChIP 
experiments.  
Given that work in the liver has suggested that a single factor may 
influence global Hdac3 localization within a given tissue (Feng et al., 2011), an 
unbiased screen for Hdac3 protein interacting partners in neural crest cells could 
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also identify the mediators of Hdac3 genomic targeting. In such a screen, Hdac3 
would be precipitated from neural crest cells and its interacting partners identified 
by mass spectrometry. To this end, we have designed and are cloning a 
construct in which Hdac3 is tagged with an AviTag that leads to its biotinylation 	  
(Wang et al., 2006). This strategy has previously been used to identify interaction 
networks between transcription factors and chromatin remodeling enzymes in 
early developmental processes (Wang et al., 2006). Biotin-tagged Hdac3 could 
be expressed in cultured neural crest cells and precipitated with high affinity by 
streptavadin; such a strategy would maximize the signal to noise ratio in a 
proteomic screen for Hdac3 interacting partners, and identify candidate 
interactions that could be further explored.  
 
Are the functions of Hdac3 in neural crest mediated by interactions with 
non-histone proteins? 
 Classically, Hdacs act as transcriptional repressors by directly 
deacetylating histone tails. However, class I Hdacs can also regulate 
transcription by directly deacetylating non-histone targets (LeBoeuf et al., 2010). 
Hdac3 has been proposed to directly deacetylate Mef2d and p53 to regulate their 
activity (Gregoire et al., 2007, Zeng et al., 2006). It is possible that the 
phenotypes elicited by deletion of Hdac3 in neural crest arise due to 
hyperacetylation of transcription factors in the absence of this important 
regulatory enzyme.  
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Interestingly, the class III Hdac Sirt1 has been shown to directly 
deacetylate the Notch effector molecule NICD, suggesting the intriguing 
possibility that Hdac3 could deacetylate NICD to regulate OFT development 
(Guarani et al., 2011). However, this study identified the hyperacetylated form of 
NICD as the active form, which is not consistent with a model in which Notch 
activity is decreased in the absence of direct deacetylation from Hdac3. 
One strategy to identify candidate transcription factors that may be direct 
targets of Hdac3 deacetylation is to analyze microarray data from Hdac3-
deficient versus control tissue, in order to identify patterns of dysregulation 
among the known targets of individual transcription factors. An additional strategy 
to identify potential non-histone targets of Hdac3 deacetylation involves the use 
of the unbiased proteomics screen described above. For candidates identified 
through these strategies, interactions could subsequently be explored in the in 
vitro model systems employed in Chapters 2 and 3. 
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Concluding Remarks 
  
 The work described in this dissertation has identified downstream targets 
and processes in neural crest development that are regulated by Hdac3. We 
have shown that Hdac3 is essential for neural crest-mediated craniofacial and 
cardiovascular development, while it is not required for neuroendocrine 
development. An exciting area of future research will involve indentifying the 
upstream pathways and stimuli that regulate Hdac3 function in neural crest cells. 
These studies will shed further light on the molecular regulation of neural crest 
development, and provide a more complete understanding of how external stimuli 
are linked to heritable changes in progenitor cell gene expression. 
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Figure 4.1 
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Figure 4.1. Model of Hdac3 regulation of craniofacial development. Hdac3 
regulates both neural crest cell survival as well as ossification during craniofacial 
development. Regulation of ossification occurs through a Runx2-mediated 
pathway. We propose that Hdac3 is responsible for repressing a repressor of 
ossification, through histone deacetylation. Hdac3-mediated regulation of the cell 
cycle occurs through transcriptional silencing of Bmp4, which we hypothesize is 
also mediated by the transcriptional repressive functions of the Hdac3 complex. 
The histone deacetylase activity of Hdac3 requires its association with NCoR 
and/or Smrt in a corepressor complex. 
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Figure 4.2 
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Figure 4.2. Model of Hdac3 regulation of cardiac outflow tract development. 
Smooth muscle differentiation in the aortic arch arteries relies on a Notch-
Jagged1 positive feedback loop. Hdac3 is required for propagation of this 
feedback loop in neural crest cells. We hypothesize that Hdac3, through its 
activity as a transcriptional repressor, inhibits the expression of an inhibitor of this 
process. 
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Appendix. Diet induced lethality due to deletion of the 
Hdac3 gene in heart and skeletal muscle 
 
This appendix contains data that has been published in the Journal of Biological 
Chemistry in a collaborative project with the Zheng Sun of the Lazar lab (Sun et 
al., 2011). In addition to experimental design and data analysis, I directly 
contributed data in figures 1A, 2B,D, 3A,C,D. 
 
Summary 
 
In chapter 1, I discussed phenotypes arising from cardiac deletion of 
Hdac3 in different stages of cardiac development. Briefly, deletion of Hdac3 in 
bipotent progenitor cells results in premature cardiomyocyte differentiation and 
proliferation defects; deletion of Hdac3 in ventricular cardiomyocytes results in 
inefficient lipid metabolism, leading to oxidative damage, progressive heart failure 
and death. 
In this appendix, I describe the results of Hdac3 deletion in differentiated 
cardiomyocytes. In the context of the aforementioned studies of Hdac3 in cardiac 
development, this work provides an example of the differential roles played by 
Hdac3 within a single cell lineage at different developmental time points. 
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Results and Discussion 
 
 Excising Hdac3 with Cre recombinase under the control of the muscle 
creatine kinase promoter (Mck-Cre) results in progressive deletion of Hdac3 in 
cardiomyocytes and skeletal muscle during the perinatal period (Appendix, 
Figure 1). Mck-Cre; Hdac3f/f mice fed a normal diet (11% kcalories from fat) are 
viable, with no reduction in survival (Appendix, Figure 2A). At 4 months of age, 
they show mild cardiac hypertrophy, but no upregulation of markers of heart 
failure (Appendix, Figure 2B,C). Echocardiography reveals increases in ejection 
fraction and fractional shortening, consistent with mild, early stage cardiac 
disease, and histological analysis of 8 month old hearts shows mild infiltrate at 8 
months of age (Appendix, Figure 2D-F).  
 Expression profiling of 4-month-old Mck-Cre; Hdac3f/f hearts reveals that a 
different subset of metabolic genes is dysregulated, compared to in αMHC-Cre; 
Hdac3f/f hearts (Appendix, Table 1).  Genes found to be downregulated in Mck-
Cre; Hdac3f/f hearts include important regulators of the mitochondrial response to 
lipid overload (Appendix, Table 1). Therefore when placed on a high fat diet (60% 
fat by kilocalorie), these mice exhibit profound cardiac defects. Four-month-old 
Mck-Cre; Hdac3f/f mice treated for three months on a high fat diet demonstrate 
pronounced cardiac hypertrophy, as measured by heart weight: tibial length ratio, 
expression of markers of heart failure, and increased myocyte diameter 
(Appendix, Figure 3A-D). These hypertrophic hearts are functionally 
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compromised, with significant decreases in contractility and ejection fraction, as 
well as wall motion abnormalities consistent with destruction of normal 
myocardial architecture (Appendix, Figure 3E,F).  Histological analysis confirms 
this disruption of normal myocardial architecture, revealing significant fibrosis and 
a mononuclear cell infiltrate in Mck-Cre; Hdac3f/f hearts (Appendix, Figure 3D).  
These cardiac abnormalities lead to lethality between 4-6 months (Appendix, 
Figure 3G).  The severity of the cardiac abnormalities in Mck-Cre; Hdac3f/f mice 
on a high fat diet lies in stark contrast to the subtle abnormalities of littermate 
controls fed normal chow, demonstrating an important interaction between 
environmental stimuli – in this case the nutritional environment – and the function 
of Hdac3 as a modulator of gene expression. 
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Table A.1. Genes differentially expressed in 6 week old (normal diet) Mck-
Cre; Hdac3f/f versus Hdac3f/f hearts 
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Figure A.1 
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Figure A.1. Efficient postnatal deletion of Hdac3 In Mck-Cre; Hdac3f/f 
hearts. A. qPCR analysis of Hdac3 transcript in mice at the age of 1-day, 1-
week, 3-week, and 6-week. n=4. Arbp was used as a reference control. Error bar 
= S.E.M. Asterisks indicate p < 0.05 by two-sided studentʼs t-test. B, Western blot 
analysis of 4-month-old mice. KO: Mck-Cre; Hdac3f/f. WT: littermate Hdac3f/f.
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Figure A.2 
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Figure A.2. Mild alterations in Hdac3-deficient hearts on normal chow. A. 
Kaplan-Meier survival curves and body weight are unchanged on normal chow. 
n=12-15. B. Gross picture of hearts at the age of 4-months, and heart weight 
(HW) to tibia length (TL) ratio of 4-month-old mice on normal chow. n=7-8. C. 
qPCR analysis of 4-month-old mice for cardiac atrial natriuretic peptide (ANP) 
and brain natriuretic peptide (BNP), markers for heart failure. n=3. D. Trichrome 
stain of hearts from 8-month-old mice, revealing normal myocardial architecture. 
E-F. Echocardiography analysis of cardiac structure and function on 4-month-old 
mice on normal chow. . n=4-5. E. Parameters measuring cardiac function reveal 
subtle abnormalities in Hdac3-deficient hearts, representing increased cardiac 
function. EF: left ventricular ejection fraction FS: left ventricular fractional 
shortening. F. Parameters measuring cardiac structure reveal subtle 
abnormalities in Hdac3-deficient hearts. IVRT: isovolumic relaxation time; LVIDd: 
left ventricular diameter during diastole; LVIDs: Left ventricular diameter during 
systole; LA: left atrium area; LVPW: LV posterior wall thickness during diastole; 
RVAW: right ventricular anterior wall thickness; IVS: interventricular septal 
thickness during diastole. 
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Figure A.3  
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Figure A.3. Dietary lipid overload induced severe cardiac defects in mice 
lacking cardiac Hdac3. A. Gross picture and heart weight (HW) to tibia length 
(TL) ratio of hearts from 4-month-old mice after 3 months on a high fat diet 
(HFD). n=4-5.  B. qPCR analysis of myocardial ANP and BNP from 4-month-old 
mice. n=4-5. C. Wheat germ agglutinin (WGA) staining of cross sections of 
ventricles from 4-month-old mice on HFD. Myocyte diameter was quantified using 
6 random 20x fields of view from 3 WT and 5 KO hearts. D. Trichrome stain of 
hearts from 4-month-old mice on HFD shows extensive areas of fibrosis (blue) 
and destruction of normal myocardial architecture. E-F. Echocardiography 
analysis of cardiac structure and function on 4-month-old mice on high fat diet. 
n=4-5.  E. Cardiac structure data. F. Contractile function data and representative 
short-axis M-mode images from echocardiography. G. Kaplan-Meier survival 
curves on high fat diet (HFD). n=10 for WT, n=12 for KO. KO mice have normal 
weight gain on HFD. 
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